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ABSTRACT
Traurnatic brain injury (TBI) is one of the leading causes of death and
disability in industrialized countries. The neurological consequences of such an ïnjury
are complex and may impair any of sensory, motor, or autonomie frmnctions. Primary
injuries occur at the moment of injury and are uTeversible, whereas secondary injuries
eau evolve from the initial primary injury, and are ofien the focal targets of therapeutic
interventions.
Glutamate is a major excitatory neurotransmitter in the brain. Over-stirnulation
of postsynaptic glutamate receptors due to increased extraceilular glutamate levels
could result in neuronal loss from excitotoxicity. and constitutes one of the major
secondary injuries following TBI wherc a rise in brain glutamate levels bas been
documented both in hurnans and animais.
This thesis investigates excitotoxic mechanisms and the role of glutamate
traisporters in the pathophysiology of TRI. A weii-characterized rat model of TRI,
invoïving lateral parasagittal fluid-percussion injury (fPI), is utilized to investigate the
events involved in the early increase of extracellular glutamate following TBI.
In Articie 1, it is demonstrated that the downregulation of brain glutamate
transporter GLT-lv protein leveis occurs in the injured cerebral cortex and is
correlated closely with neuronal loss seen in the same injury area. Such loss in GLT
1v may result in irnpaired glutamate uptake, giving risc to excitotoxic injury following
FPI.
In the second article, it is dernonstrated that a transient rise of complexin I and
II protein levels is detccted in the injured cerebral cortex that can lead to the increased
neurotransmitter release from presynaptic neurons. Changes in complexin levels were
completely blocked by N-acetylcysteine (NAC) administered 5 minutes foiiowing
trauma, suggesting an involvement of oxidative stress. Neuronal loss was also reduced
in the injured hemisphere with post-TBI NAC treatment.
In the third article, an increase in EAAT4 protein levels was detected that may
represent a compensatory mechanism to counteract the loss in GLT-lv protein levels
nfollowing TBI. This EAAT4 increase observed following injury was primarily
localized to celis morphologically resembling astrocytes.
Altogether, these resuits suggest a complex process of excitotoxic injury is
involved in the pathophysiology ofFPI.
Key words: Traumatic brain injury, fluid-percussion injury, glutamate, glutamate
transporter, GLT-lv, EAAT4, neurotransmitter release, complexin I, complexin II,
excitotoxicity, antioxidant.
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RÉSUMÉ
Les traumatismes crâniens sont l’une des causes majeures de décès et de
dysfonctions physiques chez les adultes dans les pays industrialisés. Les conséquences
neurologiques d’un traumatisme crânien sont complexes et affectent les fonctions
motrices, la sensation et la mémoire. Les traumatismes sont classifiés dans deux
catégories (primaire et secondaire) selon le type et l’aspect de la lésion. Les lésions
primaires se manifestent au moment du traumatisme et sont irréversibles. Par contre,
la progression des lésions primaires peut entraîner des lésions secondaires qui
nécessiteront des interventions thérapeutiques.
Le glutamate est un neurotransmetteur excitateur majeur dans le cerveau. Des
niveaux élevés de glutamate extracellulaire peuvent entraîner une surexcitation des
neurones post-synaptiques chez les patients atteints de traumatismes crâniens, causant
une dépolarisation des neurones suivi de l’élévation de la concentration de calcium
intracellulaire et de l’activation des mécanismes apoptotique ou nécrotique, causant la
mort des neurones par un phénomène d’excitotoxicité. Ceci constitue une des
conséquences secondaires majeures des traumatismes crâniens tel que démontrées par
l’élévation de la concentration cérébrale de glutamate observée chez les patients ainsi
que dans les modèles animaux de traumatismes crâniens.
La présente thèse vise à explorer les mécanismes excitotoxiques et le rôle des
transporteurs de glutamate dans la physiopathologie des traumatismes crâniens. Un
modèle de traumatismes crâniens latéro-parasagittale (traumatismes par percussion
hydraulique) a été utilisé pour étudier les mécanismes impliqués dans l’augmentation
du glutamate extracellulaire chez le rat.
Le chapitre 2.1 (Article 1) démontre une baisse des niveaux d’expression du
transporteur du glutamate GLT- lv dans la région cérébrale traumatisée qui est en
corrélation avec la perte neuronale. La diminution des niveaux de GLT- lv entraîne
une perte de la capacité de re-capture du glutamate dans la région affectée résultant en
une augmentation de la susceptibilité des neurones à l’excitotoxicité.
Dans le chapitre 2.2 (Article 2) une augmentation des niveaux d’expression
des protéines Complexin I et Complexin II est observée dans le cortex cérébral
iv
traumatisé, ce qui suggère une propension pour la relâche des neurotransmetteurs pré-
synaptiques dans cette région. Cette augmentation est entièrement bloquée par
l’administration de l’anti-oxydant N-acetylcystéine (NAC), ce qui démontre un rôle du
stress oxydatif. Le fait que la perte des neurones soit réduite dans l’hémisphère touché
après l’administration de NAC suggère que l’augmentation des Complexins peut
contribuer à la physiopathologie des traumatismes crâniens.
Dans le chapitre 2.3 (Article 3), nous avons observé une augmentation des
niveaux d’expression du transporteur du glutamate EAAT4 consécutif aux
traumatismes suggérant qu’un mécanisme prend place pour compenser la perte des
niveaux d’expression de GLT-lv. Cette augmentation de EAAT4 a lieu dans des
cellules dont la morphologie est caractéristique de l’astrocyte.
En conclusion, les résultats présentés dans cette thèse démontrent que des
mécanismes d’excitotoxicités complexes sont impliqués dans la physiopathologie des
traumatismes crâniens.
Mots clés: traumatismes crâniens, percussion hydraulique, glutamate, transporteurs du
glutamate, GLT- 1v, EAAT4, neurotransmetteurs, complexin I, complexin II,
excitotoxicité, anti-oxydant.
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1CHAPTER 1
REVIEW 0F LITERATURE
21. Introduction
1.1.Introduction to traumatic brain injury (TRI)
1.1.1. Major causes and consequences of TBI in humans
Traumatic brain injury is one of the leading causes of death and disability
among chiidren ami young aduits in industrialized countries (Waxweiler et al., 1995).
In the United States. about 2 million cases are reported every year with approximately
500,000 people being hospitalized (Weight, 199$). In Canada, approximateiy 50,000
individuals sustain the injury each year (Statistics Canada, 1994). Major causes of
injury are principally from motor vehicle accidents, falis, violence or sports related
injuries. According to the National Institutes of Health (NIH), the highest incidence is
arnong persons 15 to 24 years of age and 75 years and older, with an additional less
striking peak in incidence in children ages 5 and younger (Annonyrnous, NIH
Consensus Statement, 1998). Males are twice more involved in T3I than females.
Nevertheless, no one is safe from it, and TBI is a disorder of major public health
significance as it affects person of ail ages and ofien resuits in serious disabilities.
The neurological consequences of TBI are complex, as sensory, motor, and
autonomic functions can be compromised. Most of these complications are apparent
within the first days or months following injury. Some long-terrn sequelae include a
variety of movernent disorders, seizures, headaches, ambient visual deficits, and sleep
disorders. Cognitive consequences of TBI are sirnilarly complex, producing different
functional problems. Some of the most persistent problems include memory
impairment and difficulties in attention and concentration. Deficits in language use
and visual perception are common, but ofien unrecognized. Frontal lobe functions,
such as the executive skills of problem-solving. abstract reasoning, insight, judgrnent,
planning, information processing, and organization, are vuinerable to TBI NIH
Consensus Staternent, 199$).
31.1.2. Primary injury
TBI is a rnultifaceted disorder. Primarily, patients with brain injury suffer from
surface contusion and laceration, focal or diffuse intracranial hemorrhages, and diffuse
axonal injuries. These primary injuries (especially a rise in intracranial pressure, ICP)
can evolve into more serious secondary events such as an increase in post-traurnatic
ischemic burden, oxidative damage, and alterations of endogenous neurochernical
mechanisms that may be preventable with proper treatment and the advent of
therapeutic strategies.
Table 1.1. The Glasgow Corna Score. Patients are scored upon their ability to
repond to the visitai, verbal and physicai stimuli and graded accordingÏy. A total of
13 or higher miÏd brain injuly; 9 b 12 = moderate injtlly, 8 or less = severe brain
iijury. Adaptedfrorn Ciausen and BuÏÏock (2001) with modifications.
Glasgow Coma Score (GCS)
Eye openîng
Respond
spontaneously ;4
Respond to speech ; 3
Respond to pain ; 2
No response J
Verbal response
Confiised ; 5
disoriented ;4
Inappropriate words ; 3
Incomprehensible
sounds 2
No response ; 1
Moto r response
Obeys comrnands ; 6
Localize pain ; 5
Withdraws to pain ; 4
Abnormal flexion
to pain ; 3
Extension to pain ; 2
No response ; 1
4Irnmediately afier the injury, patients frequently suffer from a combination of
hypotension and hypoxernia between the time of injury to being hospitalized, and low
cerebral blood flow is also flot uncommon. Therefore, it is crucial to maintain
sufficient blood flow as well as adequate tissue oxygenation as early as possible
(Clausen and Builock, 2001). Acute assessment of neurological deficits via Glasgow
Coma Score (GCS) provides practical early diagnosis of severity of injury (GCSs are
indicated in table 1). following hospitalization, stabilization of ail vital systems,
establishment of a comprehensive monitoring and a complete assessrnent of the extent
ofthe primary damage are crucial (Ciausen and Bullock, 2001). These are ofien done
with X-ray CT (computerized tomography, see figure 1). factors that may increase
likeliness of complications (secondary injury) via elevating ICP such as epidural,
subdurai or intracerebral hematomas, or mass lesions are surgically removed at this
time. Also, monitoring of ICP and cerebral perfusion pressure (CPP) is necessary and
should be foliowed through.
1.1.3. Secondary injury; post-traumatic ïschemic insuits and its consequences
The secondary events that follow primary injury are complex, involving a
myriad of pathological developments, many of which occur simultaneously. Most
tirnes in the patient’s brain, tissue oxygenation is cornpromised. Cerebral metabolic
rate for oxygen (CMRO2) can be different from the cerebral metabolic rate for glucose
(CMRgiu), and hence hypoxic injury can follow trauma even if adequate cerebral blood
ftow is rnaintained, especially when acute pulmonary arrest (apnea) is flot uncommon
in TBI. With reduction of Pa02 to 65 mm Hg, humans have an impaired ability to
perforrn complex tasks, and a graduai decrease of Pa02 eventually causes short-tenn
memory loss and loss of unconsciousness (Zauner et al., 2002). Adequate ventilation
is therefore essential in reducing the hypoxic damage following trauma.
Hernorrhages resuiting from the injury, in addition to increasing ICP by
occupying space in the brain, can play a crucial role in post-traumatic ischemic insuits,
as this ofien leads to focal regions of vessel spasm (Mendelow et al., 1984), mediated
in part by increases in oxidative stress. Such vasospasm can substantially lower
5regionaÏ blood flow, increasing vulnerability towards the incidence of post-traumatic
ischemic events. Mthough global physiological parameters such as cerebral blood
flow (CBf) show no evidence of a direct connection with ischemia in trauma patients,
regional vulnerability towards ischemia increases following IBI. In fact, following
head injury, increased ischemic brain volume characterized by reduced local CBF and
increased oxygen extraction fraction (OEF) can lie detected in regions of brain
following trauma by voxel-based analysis using positron emission tomography (PET)
(Figure 1.1).
Figure 1.1. PET images afler early head X-ray CT tïeft), PET CBf (‘center,),
and OEF «ight) images oblainedftom a 42-year-old woman 16 hours afler i;!jmy
foiowing evacuation of ci subdural hematoma (shown on the left hemisphere). The
intracraniai pressure was 12 mm Hg, cerebrat perfusion pressure was 78 mm Hg, and
PaCO2 was 36 mm Hg. Note the small amount of residuat subdura! blood wïth
minimal midtine shft and the rnarked reductions in CBf anti increases in Off in the
cerebral hemisphere underïying the evacuated subdural hematoma. PEI positron
emission tomegraphy; C7 compured tomography; C’EP cerebrai bloodflow; OEP
oxygen extractionfraction. Adaptedfrom Cotes et ai, (2004).
6The likelihood of ischemic events is further encouraged partly due to the fact
that local CBf is unable to increase in response to the heightened metabolic demand.
In animal models of 131, a decrease in local CBF associated with an increase in the
local CMRgic has been demonstrated acutely by autoradiography and PET imaging
(Ginsberg et al., 1997; Richards et al., 2001). These resuits point to an early
uncoupling of glucose metabolism and blood flow in the contused brain as a potential
cause of the increased post-traumatic ischemic burden. Resulting post-traumatic
ischemic brain burden could, if unattended, lead to complications that incÏude elevated
ICP, reduced CPP, global ischemic brain damage (Mendelow and Crawford, 1997)
and, ultimately, brain death.
It has been suggcsted that CMRgiu and CMRO2 reflect astrocytic and neuronal
metabolism, respectively, following brain injury (Magestretti et al., 1999). Shortly
following cerebral injury, brain lactate levels increase. In normal brain where
oxidative metabolism is favored, lactate production from glucose by astrocytes can
enter neurons and be converted back to pyruvate, which enters the Kreb’s cycle
(lactate shuttie hypothesis). Under compromised oxygen levels, oxidative metabolism
is irnpaired, and lactate cannot be rnetabolized by neurons thus resulting in a buildup
of tissue lactate content.
This rise in lactate appears to resuit from increased anaerobic conversion of
glucose to lactate due to the heightened energy demand which may partly represent an
attempt to restore normal ionic balance, as application of the Na7K-ATPase inhibitor
oubain is known to attenuate the lactate increase (Kawamata et al., 1995). Ion
transport requires a large portion of the energy requirement of the brain tissue, as it
bas been suggested that approximately 75 % of the increase in oxygen consumption is
used to restore adenosine triphosphate levels afler neuronal depolarization (Siesjô,
1978). Tonic perturbations mediated by excitatory amino acid-coupled ion chaimels
strongly stimulate energy-dependent ion pumps and thereby activate glycolysis
following concussive brain injury (Katayama et al., 1990; Kawamata et al., 1992).
Such an increase in glycolysis may be largely responsible for the increased local
CMRgic observed following the injury, contributing to a damaging cycle of increased
rnetabolisrn, oxidative stress, juxtaposed ischernic vulnerability and ftirther ischemic
7release of glutamate, potentially leading to a secondary wave of ioninc imbalance and
an exacerbation ofpost-trauma cerebral edema (Figure 1.2).
fl3I
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Figure 1.2. Schematic diagram representing how trauma resuits in
increased ischemic burden and the devastating secondaiy ischemic
injury cycle that could also exacerbate edema. C’BF cerebral blood
flow, CMRGlu, cerebral metabolic rate for glucose, EAA, excitatory
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1.1.4. AnimaI models ofTBI
Given the necessity for understanding the pathophysiology of TBI and
screening for new therapeutic interventions, a well-characterized animal model is
essential. $uccessful models of trauma should be able to precisely vary the severity of
$injury and the response must be quantifiable and reproducible between different
investigators and laboratories (Teasdale et aI., 1999; Graham et al., 2000) and replicate
the type of severity and injury observed in man.
Due to the variety of human brain injuries and their causes, no single animal
model can successflully represent various aspects of human TBI. As a consequence,
there are now many different animal models of TBI, each modeling some aspect of
human injuries. Pathophysiological and biochemical parameters such as brain edema,
increased ICP, elevated brain neurochemicals and hemorrhages can be commonly
measured in most animal models of TBI. However, depending on the characteristics
and severity of each model, additional parameters may be present or absent. For
example, a focal penetrating trauma may consistently show evidence of intracerebral
hernoiihage, but this may flot be the case in closed head injury. Also, a diffuse closed
head model will better replicate pathological characteristics of diffuse axonal injury
than a rnild penetrating focal model of TBI. In this section, these different models of
trauma will be discussed.
1.1.4.1. Inertial acceleration brain injury
A major feature of human closed head injuries is the movement of the brain
within the skull rather than a direct impact to the head which can be represented as a
rapid rotation of the head. The shearing mechanism created by controlled, fixed
angular rotational movement creates accelerationldeceleration forces in the brain that
results in diffuse axonal injury located in white matter and brain stem. A non-impact
head acceleration model using non-human primates and miniature swine most closely
replicates the complex pathobiology of human TBI (Smith et al., 1997; GeimareÏli et
al., 1982). owing to the similarity in brain mass in these species and hence better
resembling physical force applied to human brain upon injury. However, there are
certain drawbacks of this model such as the high cost and size of the animal used for
experirnental purposes. The latter is especially the case since the use of rodents in such
a model has been limited due to the fact that the rotational accelerational forces
necessary to induce damage to CNS structures increase exponentially with decreasing
9brain size, and no injury device exists that can reliably produce a comparable TBI in
rodents at present (Marmaru et al., 1994).
1.1.4.2. Indirect brain injury
An explosion causing peripheral blast trauma without direct head injury can
also resuit in significant brain damage with consequent cognitive and motor system
deficits. This type of indirect dynarnic brain injury can be represented using a rodent
model whereby metal cylindrical tubing closed at one end is used to house the
anesthetized animal and in which plastic explosive or cornpressed air generates blast
pressure waves near the closed end of the tube (Cernak et al., 2001). The resulting
blast wave from detonation of the explosive can cause neuronal damage and swelling
in the cerebral cortex as well as astroglial changes in addition to peripheral trauma,
and may represent many features of brain damage observed in victims of an explosion
(Cernak et al., 2001).
1.1.4.3. Closed head, non-penetrating injury
Impact to the brain can ofien cause non-penetrating closed head injuries,
especially in automobile- and sports-related accidents. The weight drop model, in
which the animal (usually rat or mouse) is exposed to a free-falling, guided weight, as
well as the impact acceleration model where a steel protection plate is placed over the
head of animal to avoid skull fracture from weight drop of high severity, are two such
concussion-type animal models, representing diffuse clinical TBI (Cernak, 2005).
These models produce concussion-type injuries where focal and diffuse axonal injury
is the major pathological outcome. Disadvantages of such models where impact is
driven by gravitational force include risks of rebound injury occuning due to a
rebounding impactor, and variability of outcome resulting from such an uncontrolled
additional insult.
Cold lesion injury, also known as cryogenic (freezing) injury, is caused by
exposing the skull and placing a cotton swab soaked in liquid nitrogen or a metal
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probe cooled with powdered dry ice upon it. Upon lesioning, the animal exhibits a
depression of local cerebral glucose utilization associated with increased brain
metabolites such as ATP, phosphocreatine, glucose and lactate in the injured cortex
(Pappius, 1981; Buczek et al., 1991) that correlates well with behavioral deficits
(Colle et al., 1986). Cold lesion injury in rodents also resuits in disruption of the
blood-brain barrier and reproducible vasogenic brain ederna, presumably caused by
the rupture of capillary endothelial celis by ice crystals (Murakami et al., 1999).
1.1.4.4. Penetrating head ïnjury
Penetrating head injury with direct brain deformation can be represented by
models where the injury is delivered through craniotomy or a direct skull perforation
produced by a missile-type force. Direct cortical deformation models include injury
causcd by a vacuum pulse of clinically relevant duration (<1 OOms), microinjection of
a fluid containing Zymosan (an inert particle macrophage activator),
lipopolysaccharide, latex microspheres to induce progressive cavitation, as well as
stab wound (Cernak, 2005). Among these, the stab wound (as well as needle puncture)
injury is performed with craniotomy followed by a controlled lowering of a needle or
a blade. The resulting injury causes limited lesions with reactive gliosis. However,
these direct brain-deformation models do flot usually cause significant long-term
deficits that would be important for representing clinical IBI, because of the absence
of extensive diffuse injuries (Cernak, 2005).
The ballistic (gunshot) injury model represents another interesting penetrating
head injury model where metal spheres or inflatable projectiles of known weight
(bullets) are shot at a precise velocity and distance from the head of the targeted
animal. The use of a controlled gunshot enables calculation of energy transferred by
the penetrating bullet, facilitating correlation of the resulting neuropathology with
injury severity. The gunshot wound model performed on the rat resuits in volumetric
increases in intracranial hemorrhage and lesion size related to injury severity,
astrogliosis, macrophage infiltration, neurological deficits, as wett as occurrence of
cortical spreading depression and seizures (Williarns et al., 2005). However, an
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increase in missile energy, i.e. high energy wounds also elevates the incidence of
respiratory arrest in the cat missile wound model (Carey et al., 1989).
1.1.4.5. Penetrating injury with combined characteristics
The penetrating injury models most frequently used are controlled cortical
impact injury (CCII) and fluid-percussion injury (FPI) models. In addition to the fact
that these models are the most well-characterized, they have advantages over other
penetrating injury models because of the presence of diffuse injury. CCII model is
sometimes described as a rigid percussion model. The CCII model utilizes a metal
impactor in which the velocity of impact and depth of deformation can be tightly
controlled, representing certain advantages over fluid-percussion. The resulting injury
from cortical impact is a more focal type of injury compared to that of FPI, which may
have implications with respect to behavioral suppression and/or ftinctional alterations
resembling coma (Dunn-Meynell and Levin, 1997). The ease of controlling
deformation parameters with pneumatically driven devices (tirne, velocity, and depth
of impact) and thus the ability to control the severity of injury is one of the advantages
that CCII represents over FPI. In addition, CCII causes significant brain edema
following injury that is both vasogenic and cytogenic in nature, as opposed to highly
vasogenic brain edema following cold-lesion injury (Unterberg et al., 1997), thus
representing the human cortical trauma more appropriately than cold lesion injury.
However, one shortcoming of CCII is the lack of brain stem deformation, resulting in
minimal mortality as the severity increases, compared to FPI or closed head
accelerationldeceleration models.
As is true for CCII, fPI can also be differentiated between a vertex model and
that of a lateral model depending on the location of trephination. However, in FPI, the
conventional vertex model has a disadvantage cornpared to the lateral injury model
due to the high incidence of mortality as the severity increases, presurnably by direct
compression of the brainstem. In addition, midline FPI (Dixon et al., 1989) does flot
reproduce prolonged unconsciousness in animaIs, a key feature of severe trauma
patients. Lateral fPI was originally designed to reproduce coup-contrecoup-type
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contusion in animais (Mclntosh et al., 1989). Although this original goal was neyer
actually achieved for the rnost part, lateral FPI is the rnost popular and well
characterized experimental model of TBI today, producing both focal and diffuse
injury characteristics (Povlishock, 1994; Hicks et al., 1996) that closely represent
closed head injury in humans (Mclntosh et al., 1989).
1.1.4.6. In vitro models ofTBI
In vitro models using cdl cultures offer certain advantages over animal models
such as the ease of use, cost efficiency and reproducibility of outcorne. In addition, the
effect of mechanical stress on a specific cell type can be studied by culturing neurons,
astrocytes, and other celis of the central nervous system. There are several types of in
vitro models of brain trauma that partially replicate the mechanical aspects of
transection, compression, acceleration, stretch and shear injury documented in animal
models ofTBI.
The transection model includes either the use of a plastic stylet to scrape/cut
the celis, or use of a laser to perform microsurgery on a single cell. The laser
transection model provides exquisite control over injury parameters, but mechanical
data (force, strain, strain rate) concerning the process of transection cannot be obtained
(Morrison et al 1997).
The compression model attempts to model in vivo spinal cord injury.
Typically, a weight is dropped on to organotypically cultured spinal tissue. However,
this type of model offers littie insight into the biomechanics of the tissue injury.
The hydrostatic pressure model utilizes pressure for a given duration to cause
damage to cells. Due to the high pressure and long duration used in this mode!, it may
flot appropriately represent the actual injury in intact brain. Although there is a
transient FPI model ofhydrostatic pressure with shorter duration (Shepard et al., 1991),
the mechanical injury mechanism associated with in vivo compression trauma may flot
be properly reproduced by hydrostatic pressure (Morrison et al., 1997).
The acceleration model utilizes a flask of cultured ceils exposed to an
acceleration force created by an impact pendulum, as high as 200 g (Lucas and Wolf,
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1991), aimed at replicating damage following human head injury that may resuit from
shear strain of brain matter due to inertial loading. However, damage to the ce!ls is
only detected following repetitive, tangential acceleration thus limiting its use to
modeling of injuries associated with multiple impact.
Another model aimed at studying the effects of inertial loading of the brain is
the hydrodynamic mode!. This model shears or stretches cultured ce!ls using
hydrodynamic forces generated by a rotating meta! plate over the ce!ls. One advantage
of the hydrodynamic mode! is that the ceils can be visualized under a microscope
during the injury process.
The ccl! stretch model uses a F!ex P!ate (E!lis et a!., 1995) to cause
deformation of wells resu!ting in a strain to the ce! is. This mode! has achieved
widespread acceptance and use due to the simp!icity ofthe method.
Easy accessibi!ity, highly reproducible resu!ts and relative!y !ow costs as well
as tight and facilitated control over the extrace!lu!ar milieu provide these in vitro
models of trauma with several advantages over anima! models of TBI. In addition, the
effect of mechanical stress on individual ccli types can be studied in vitro by culturing
neurons and g!ia! ce!ls separate!y. However, each in vitro mode! a!so possesses a
certain degree of shortcomings. for examp!e, the shortness of duration that an
organotypic culture cari be rnaintained, the fact that prirnary celi cu!tures !ikely
represent immature ceils because they originate from the brains of embryonic or
prenatal animais, and that immortalized ce!! !ines do flot appropriately represent
norma! brain celis. Despite these limiting factors, in vitro trauma rernains a valid and
attractive approach to studying injury processes at the cellular feve!.
1.1.5. Fluid-percussïon injury
The !ateral fPI model of TBI in rodents produces injury due to the impact of a
rapid fluid bo!us which strikes the intact dura mater. Minor surgery is perforrned prior
to injury that exposes the dura by trephination of a burr ho!e of 4.8 mm in diarneter
over the lefi hemisphere of the brain. FPI can be divided into mild (1-1.5 atrnospheric
pressure), moderate (2-2.5 atm), or severe (2.5-3.5 atm), rneasured with a
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computerized pressure pulse detecting device, where injury is reproducible and varies
according to thc severity of insuit.
Blood-brain barrier disturbance, loss of consciousness, and altered CBF have
consistently been observed in the fPI model. Immediately afier trauma, CBf increases
in the injured cortex to over 100% baseline (Muir et al., 1992), but then fails to 40-
50% of baseline within 15-30 min afier injury (Ginsberg et al., 1997), which has been
known to last up to 4 h and is associated with an uncoupling of local glucose
metabofism. The immediate physiological response to FPI also includes changes in
blood pressure (transient hypertension), brief respiratory arrest, elevated ICP,
decreased CPP, reduced CBF, and increased vascular resistance (Cernak, 2005).
Petechial hemorrhage, axonal damage, subarachnoid hemorrhage, tissue tears followed
by focal necrosis (ceil loss), vascular damage at grey/white interphase (gliding
contusion), apoptosis and necrosis are also reported in FPI (Cernak, 2005). In addition,
altered ionic homeostasis and increased intracellular calcium levels, elevated tissue
sodium content, impaired potassium equilibrium, EEG depression and motor,
behavioural and cognitive impairments are weYl characterized in fPI.
Although abnormal neurons are detected via Acid Fuscin and Nissl staining
methods as early as 10 minutes following insult, visible loss of neurons is flot detected
until 12 h post injury (Hicks et al.. 1996), whereas significant loss of cortical tissue as
well as shrinkage of the hippocampal pyramidal cell layer ipsilateral to injury is seen
up to one year later (Smith et al., 1997), suggesting the initial loss of neurons takes
several hours to develop, and that the lesion is progressive, with a wide window of
therapeutic intervention. Use of FPI therefore provides an opportunity to examine
detailed mechanisms of secondary injuries leading to neuronal Ïoss.
Reactive astrocytes are detected as early as 1 day following injury that persist
up to a month afier the insult (Hill et al., 1996). In addition, in regions of atrophy and
in the dentate hilus region where bilateral loss of neurons persists, reactive astrocytosis
is observed up to 1 year (Smith et al., 1997).
1.2. Rote of glutamate, the major excitatory amino acid in the brain
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Glutamate is the most abundant excitatory neurotransmitter in the brain.
Cerebral glutamate concentration is about 5-15 mmol/kg wet weight, but most of this
glutamate is maintained inside the ce!!, leading to low extracellular glutamate levels
(3-4 tM) (Danbolt, 2001). In norma! brain, the role of glutamate as an excitatory
neurotransmitter is undisputed. However, increased levels of extracellular glutamate
following head injury cause over-stimulation of glutamate receptors that may resuit in
series of secondary events, leading to neuronal ceil death. Sucli events can cause
prolonged depolarization and subsequent ionic imbalance that could culminate in
cytogenic edema, raised ICP, vascular compression and brain herniation, an ofien fatal
complication of severe head injury.
A rise in extracellular glutamate levels may exert its detrimental effect by
acting upon glutamate receptors. Cation fluxes due to excessive opening of glutamate
receptor channels lead to cellular ionic imbalance and loss of membrane potential.
furthermore, an excessive increase in the intracellular Ca2 via NMDA receptor
operated channels may result in the activation of Ca2tdependcnt enzymes as well as
increased nitric oxide production. Depending on the energy status of the celi,
apoptosis and/or necrosis may be the final outcome. Thus, understanding the structural
features of glutamate receptors may provide useful insight into the transduction
mechanisms that can lead to excitotoxicity. In the following section, an overview of
the action of glutamate on glutamate receptors in the brain will be briefly described.
1.2.1. Ionotropïc (NMDA, AMPAIKainate) receptors
Ionotropic receptors are ligand-gated ion channel proteins of heterotetrameric
or pentameric structures each consisting of 3 transmembrane spanning domains and a
cytoplasmic-facing re-entrant loop, with an extracellular N-terminal segment and
intracellular C-terminal region (Dingledine et al., 1999). Upon activation, ionotropic
glutamate receptors induce alterations in the concentration of intracellular ions, and
the intracellular carboxy-terminal interacts with a variety of intracellular proteins.
There are 3 known types of ionotropic receptors; the Œ-amino-3-hydroxy-5-rnethyl-4-
isoxazolepropionic (AMPA) receptor, the kainate receptor, and the NMDA receptor.
16
AMPA and kainate receptors are oligomeric ligand-gated ion channels with
fast kinctics that are permeable to Na and K and also to low levels of Ca2
(Hollrnann et al., 1991). AMPA receptors have a lower glutamate affinity than NMDA
receptors, but they have faster kinetics. NMDA receptors contain voltage-dependent
divalent and monovalent cation channels more permeable to Ca2 ions. There have
been five NMDA receptor subunits identified so far, NRÏ and NR2A-D (Hollmann
and Heinemann, 1994). NMDA receptors are found both within synapses as well as at
extrasynaptic locations. The final localization ofNMDA receptors may depend on the
anchoring of NMDA receptors to cytoskeletal elements in the synapse via NR1 -a
actinin interaction. For NMDA receptors, the presence of NRY appears invariant,
whereas the selection of NR2 A, B, C or D subunits determines the time constants of
opening ofthe chaimel and modifies the effect ofvarious antagonists.
1.2.2. Metabotropic glutamate receptors (mGluRs)
Metabotropic receptors are subdivided into 3 groups. Group I mGluRs includes
rnGluRl and mGluR5, are positively coupled through phosphoinositide-specific
phospholipase C to phosphoinositide hydrolysis and intracellular Ca2 mobilization,
and sensitive to quisqualate and the cyclic glutamate analogue (1$, 3R)-ACPD. Group
II rnGluRs includes mGluR2 and mGluR3, are negatively coupled to adenylate cyclase,
and also activated by (1$, 3R)-ACPD but less sensitive to quisqualate. Group III
rnGluRs include mGluR4, mGluR6, mGluR7 and mGluR8 and are also negatively
coupled to adenylate cyclase.
1.2.3. Following TBI, extracellular glutamate increases via multiple sources
Following TBI in both experimental and clinical settings, levels of
extracellular glutamate increase acutely (Faden et al., 1989; Globus et al., 1995;
Palmer et al., 1993; Bullock et al., 199$). Depending on the location of the sampling
probe, varying resuits have been reported in the concentration and the duration of the
glutamate increase. In animal models, for example, the increased levels of glutamate
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may be short lived, retuming to basal values within 4 hrs (Globus et al., 1995). In
humans, low levels of sustained increase has been observed (BulÏock et al., 1992), thus
increasing the window for therapeutic intervention.
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Figure 1.3. Multtple source ofglutamate increase following traumatic
brain injury. Post traumatic glutamate levels may rise due to different
and complex mechanisms including enhanced exocytosis- or non
exocytosis-related events and impaired glutamate removal from the
extracellular space by transporter prote in impairment/downregulation.
BBB, blood-brain barrier.
The interstitial glutamate surge following the cerebral insuit probably
originates from multiple sources (figure 1.3). Glutamate may move into brain
following disruption of the blood-brain barrier, as blood contains higher glutamate
concentrations (millimolar) than the interstitial space. Intraparenchymal hernorrhage is
often seen following brain trauma, and autoradiography following intravenous
1$
injection of t4Clabeled glutamate revealed marked extravasation of {‘4C]-glutarnate at
the site of cortical impact (Koizumi et al., 1997). Release of glutamate may also reflect
non-specific development of micropores in the ceil membrane, based on the finding
that the release of excitatory amino acids is closely related to the release of structural
arnino acids (Bullock et al., 1998). It is also possible that excessive synaptic release of
glutamate may occur following the injury, leading to glutamate overflow into
extrasynaptic regions. Last but not least, a decrease in glutamate uptake activity, due
either to functional impairment or decreased expression of the transporter protein can
also contribute in a major way to the accumulation of extraceflular glutamate.
Glutamate release as a consequence of reversal of the transporter protein could also
result in a rise in interstitial glutamate levels in the core of the lesion
(infarctionltraumatic core) where damage is most severe (Figure 1.3).
1.2.4. Altered NMDA receptor function following TBI
NMDA receptor is a heterodimeric assembÏy. thought to be comprised of two
NMDAR1 subunits and two or three NR2 subunits. NR1 is the principal constituent of
the NMDA channel, homogeneously distributed in the brain that alone can generate a
functional pore in vitro (Moriyoshi et al., 1991), whereas the NR2 is a regulatory
component with four subtypes (NR2A-D) differentially distributed in the brain and
imparting specific electrophysiological properties to the NMDA channel (Osteen et al.,
2004). It seems that in understanding ftinctional alteration of NMDA receptor
following brain injury requires consideration of the ratio of NR2 subtypes, especially
that of NR2A and NR2B, since cortical neurons with more NR2B than NR2A (low
NR2A:NR2B ratio) are more sensitive to glutamate, open for a longer period of time,
and conduct larger currents than a population with a high NR2A:NR2B ratio (Osteen
et al., 2004).
Previous studies using receptor binding techniques have suggested that the
function of NMDA receptor rnight be altered following TBI (Miller et al., 1990,
Sihver et al., 2001). An acute decrease of NMDA binding in these studies may have
indicate that receptor sensitivity to glutamate could be irnpaired. However, these
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studies did flot use the subtype-specific functional attributes of post-injury NMDARs
to differentiate between the NR2 subtypes. Osteen and colleges (2004) have shown
that a decrease of both subtypes of receptor occurs following FPI, and the
NR2A:NR2B ratio indicates that NMDA receptor becomes temporarily more sensitive
to glutamate and would remain open longer once activated. This is combined with
45calcium autoradiography and subtype specific antagonists studies suggested that TBI
induces molecular changes within NMDA receptor, contributing to the celis’ post
injury vulnerability to glutamatergic stimulation (Osteen et al., 2004).
1.2.5. Current perspective on excitotoxic injury
NMDA receptors, and AMPA’kainate receptors to a certain extent, play a
major role in excitotoxicity mediated via increase in interstitial glutamate
concentration, moreso than metabotropic glutamate receptors. This is understandable
considering the functional nature of ionotropic receptors; ion channels permeable to
+ + 2+Na , K and Ca , which are crucial in mamtalmng the iomc balance of the celi. Over
stimulation of metabotropic receptors may have rnodulatory roles via secondary
messenger pathways, rather than directly contributing in excitotoxicity. As a
consequence, application of NMDA antagonists have proven beneficial in animal
models of ischemialreperfiision injury as well as TBT, and undergone clinical trials in
the US and elsewhere.
However, past attempts to overcome excitotoxic injury in stroke and trauma
patients by application of glutamate receptor antagonists in clinical trials have suffered
a great deal of drawbacks (Ikonomidou and Turski, 2002). Many of these antagonists,
at beneficial dosages, have major side effects and are potentially dangerous. At lower
doses, synaptic tortuosity can hinder efficient drug delivery, making the half-life of
these compounds a significant factor. In addition, drugs often suffer from a relatively
short therapeutic window for application, and with the fact that many patients can
arrive at the hospital for treatment several hours afler the insult, their beneficial use
can be very limited.
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It is thus crucial at present to careftilly re-examine excitotoxic mechanisms,
particularly those involving glutamate transporters. Since these proteins perform the
major role of clearance of glutamate from the extracellular space, it is important to
understand their nature in order to develop future therapeutic strategies that may
positively impact the consequences of TBI. In addition, our current knowledge of
neurotransmitter release process following such an insuit to the brain is limited and
requires further investigation.
1.3. Rote of glutamate transporters in the brain
In brain. glutamate cannot be metabolized within the extracellular space.
Instead, glutamate is removed rapidly from the extracellular space by a class of
sodium-dependent glutamate transporters known as Excitatory Amino Acid
Transporters (EAATs). The maintenance of functional transporters near the synapse is
crucial for sequestration of synaptic glutamate, thereby providing a crisp signalling
system, as well as preventing potential toxicity by this excitatory arnino acid. In the
following section, the current literature on sodium-dependent EAATs and their
function relative to localization will be considered.
1.3.1. Sodium-dependent EAATs in the brain
1.3.1.1. Different subtypes of sodium-dependent glutamate transporters and their
localization
To date, 5 subtypes of sodium-dependent glutamate transporters have been
cloned and localized in brain and peripheral tissues: GLAST (Glutamate-partate
transporter, [EAAT 1], Stork et al., 1992), GLT- 1 (Glutamate Transporter-l, [EAAT2],
Pines et al., 1992), EAAC-1 (Excitatory Amino Acid Carrier-l, [EAAT3], Kanai and
Hediger, 1992), EAAT4 (Fairman et al., 1995) and EAAT5 (Arriza et al., 1997). In the
brain, highest levels of GLT- 1 protein are detected in the hippocampus and cerebral
cortex, whereas the cerebellum expresses highest levels of GLASI (Lehre et al., 1995)
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and EAAT4 (Dehnes et al., 199$; Furuta et al., 1997). EAAC-1 concentration is
highest in the hippocampal formation, whereas EAAT5 levels are highest in the retina.
GLAST and GLT-1 are predominantly Iocalized in astrocytes (Danbolt et al., 1992;
Rothstein et aÏ., 1994; Lelwe et al., 1995; Reye et al., 2002), whule EAAC-l, EAAT4,
and EAAT5 appear to be mostly neuronal (Berger and Hediger, 199$; Kugler and
Schmitt, 1999; Delmes et al., 199$; Aniza et al., 1997).
0f the guai transporters, it is estimated that GLT-l accounts for more than
90% of the total reconstitutable glutamate transport activity in forebrain, with several
studies indicating this to be the case. For example, uptake activity in ceil homogenates
of GLT- 1 knockout mice show less than 5 % glutamate transport activity compared to
that of wild type (Tanaka et al., 1997). In addition, antibodies to GLT-1 have been
shown to immunoprecipitate more than 95% of the reconstitutable transport activity in
crude detergent-treated extracts of forebrain tissue (Danbolt et al., 1992; Haugeto et al.,
1996). Furtherrnore, electron microscopy studies using immunogoid staining, and
other knockout studies invoiving different glutamate transporter-deficient mice
together suggest that the localization of GLT- I and GLAST account for clearance of
most of synaptic glutamate in rat forebrain (Chaudhry et al., 1995; Tanaka et al., 1997;
Peghini et al., 1997). On the other hand, the reconstitution process potentially favors
conservation of GLT- 1 activity, and may inactivate other transporters such as GLAST
(Danbolt, 2001); thus our cunent knowledge on the role of GLT-l in the brain
glutamate clearance may in fact be over-estimated.
Nevertheless, it is iess arguable that GLT-1 has the primary glutamate
transport role in the forebrain, and accounts for the majority of perisynaptic glutamate
uptake. For example, GLT-1 knockout mice develop epitepsy and are vuinerable to
cold lesion injury (Tanaka et al., 1997). GLAST is colocalized in the same astrocyte
membrane along with GLT-1, and appears to account for an estimated 20% of total
hippocampal glutamate transport, when quantification of immunocontent is considered
(Lehre and Danbolt 199$). Knockout mice lacking GLAST show loss of motor
coordination and an increased edema index following cold lesion injury in the
cerebellum (Watase et al., 1999), suggesting an important role in glutamate uptake in
this brain region. The neuronal transporter EAAC- 1 appears to be expressed in lower
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quantities relative to GLT-1 and GLAST, but is expressed at high levels in peripheral
organs such as intestine and kidney (Kanai and Hediger, 1992; reviewed by Danbolt,
2001) partly explaining the finding that EAAC-1 knockout mice develop dicarboxylic
aminoaciduria and behavioural abnormalities, but display no neurodegeneration
(Peghini et al., 1997). This suggests that the neuronal EAAC-1 transporter may play
less of a crucial role in removing extrasynaptic glutamate in the brain. EAAT4 appears
to be the predominant glutamate transporter in the Purkinje cells of cerebellum
(Danbolt, 2001), and is primarily expressed in the soma and dendrites of Purkinje celis
(Dehnes et al., 1998; Yamada et al., 1996; Nagao et al., 1997), although low levels of
expression have been detected elsewhere (Hu et al., 2003: Ward et al., 2003). EAAT5
has been localized in the retina at high levels by northern blot (Arriza et al., 1997), but
details of its protein expression studies are lacking at the present time.
1.3.1.2. Ionic dependence of glutamate uptake
As indicated above, glutamate transporters are Natdependent, with the
transmembrane gradients of Na and K providing the major driving force for their
ffinction. The currently suggested stoichiometry for the transporters EAAC- 1, GLASI,
and GLT- 1 involves one molecule of glutamate coupled to the cotransport of three Na
and one H, and the counter transport of one K (Zerangue and Kavanaugh, 1996;
Klockner et al., 1993; Levy et al., 1998), with the uptake process generating a net
positive charge moving into the cdl (Figure 1.4), which can be readily measurcd using
electrophysiological techniques. The binding of glutamate requires extracellular
sodium, whereas the internal potassium is necessary for the actual substrate transition.
Thus, the binding of glutamate is dependent on the presence of external sodium, and,
in the absence of internal potassium, the transport might facilitate exchange between
the pools of glutamate into and out of the cell. It has been suggested that this
electrogenic property of glutamate transport requires approxirnately 2% of the total
energy consumption ofthe cerebral cortex (Attwell and Laughlin, 2001).
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Figure 1.4. A simphfied diagram qf tue gtutatnate transporter
showing ionic dependence ofgÏutdllnate transport.
These transporters also display an anion charmel pfopefty thermodynamically
uncoupled to the substrate transport. The binding of glutamate to the transporters
triggers this anionic conductance (reviewed in Danbolt, 2001). The presence of anions
inside the transporter ion channels slows down glutamate transport by altering the rate
constants for transition into and out ofthe conducting state (Auger and Attwell, 2000),
and may also serve to hypeipolarize the post-synaptic membrane and diminish
synaptic activity (Amara and fontana, 2002). Some members of glutamate
transporters sucli as GLT-1, GLAST and EAAC1 display low levels of anionic
conductance. For others, such as EAAT4 and EAAT5, this anionic conductance is so
strong that h accounts for most of the current generated by glutamate uptake process
(Fairman et ai, 1995; Arriza et al., 1997).
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1.3.2. Novel C-terminal spiice-variants of GLT-1Œ
Recently, a number of studies have focused on n new spiice variant forrn of
GLT-1, GLT-lv (Chen et al., 2002; Schmitt et al., 2002). This novel form of the
predominant spiice variant of GLT- 1 (GLT- 1 x) shows high sequence homology with
GLT-la, and was not studied separately from GLT-1Œ in the past due to a lack of
Irnowiedge about this transporter. In addition, GLT- I e, another C-terminal variant of
GLT-l lias been partially cloned (Rauen et aI., 2004). The putative amino acid
sequences of different N-terminal and C-terminal spiice variants of GLT-1 are
depicted in Figure 1 .5.
The existence of nove! spiice variants with high sequence homology suggests
the distinct possibility that, of the >90% reconstitutable glutamate transport activity
attributed to GLT-1 in the forebrain, GLT-lc and GLT-lv could contribute
significantly. Indeed, since the identity of a nerve termina! glutamate transporter
remains elusive (Danbolt. 2001), there is the possibulity that one of the spiice variants
of GLT- I may prove to be such a nerve terminal glutamate transporter. However, due
to lack of detailed information on GLT- 1 c, only GLT- I y will be discussed in the
following sections.
1.3.2.1. GLT-lv
In brain, the sequence homology between GLT-la and GLT-lv is high,
differing only at its C-terminal region (Figure 1.5, Utsunomiya-Tate et al., 1997;
Schmitt et al., 2002). Although the differing C-terminal sequence of GLT-lv may
indicate altemate transporter properties, expression studies of mouse GLT- 1 in
Xenopzis oocytes and rat GLT-1 in HEK (hurnan ernbryonic kidney) ceils showed a
considerable high similarity in the functional properties between GLT-lv and GLT-la
(Utsunomiya-Tate et al., 1997; Sullivan et al., 2004). Xenopus oocytes expressing
GLT- 1 and GLT- 1v showed no noticeable difference in and Vrnax, but when both
splice variants were expressed together, Vinax showed an increase without changing
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(Utsunomiya-Tate et al., 1997), suggesting the two spiice variants interact, when
expressed in the same ceil, altering their transport properties. In addition, it is possible
that these two spiice variants non-covalently interact and form heteromultirners in vivo
as suggested by Haugeto et al (1996). Expression of both transporters in HEK293 celis
and examination of steady-state currents showed no difference in the apparent affinity
of the transporters for glutamate, with GLT- 1v being expressed in the membranes of
astrocyte somata (Sullivan et al., 2004). Morphological comparison using antibodies
directed against GLT-lv suggests that GLT-lv is predominantly located in astrocytes
(Reye et al., 2002). Also, double labeling studies have demonstrated that GLT-lu is
localized in glial processes, some of which are interposed between multiple types of
synapse, whereas GLT-lv is expressed by astrocytic processes at sites not interposed
between synapses (Sullivan et al., 2004). Based on their findings, Sullivan and
colleagues (2004) have suggested that GLT-lv may not be involved in shaping the
kinetics of synaptic signaling in the brain but may be critical in preventing spillover of
glutamate between adjacent synapses, thereby regulating intersynaptic glutamatergic
and GABAergic transmission.
Interestingly, neuronal expression has been reported for this transporter. For
example, Chen et al (2002) showed that GLT-lv protein is expressed at sirnilar levels
to GLT- 1 u in various parts of brain, and in neurons. However, in their subsequent
publication, the authors showed messenger RNA expression of GLT-lv in astrocytes
whereas GLI-lu showed neuronal expression in the hippocampus (Chen et al., 2004).
Later, Berger and colleagues (2005) showed that a subset of neurons in layer VI of
cerebral cortex expresses GLT-lv messenger RNA, and the CA3 subfield of
hippocampus expresses GLT- 1 u using in situ hybridization. It remains arguable
whether the proteins of these transporter variants are expressed in these neurons at the
present time.
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Figure 1.5. Amino acid sequences and related references of amino- and
carboxyt terminai spiice variants of GLT-1. Adaptedfrom Rauen et al., 2001.
1.3.2.2. Functional significance of C-terminal variation
Both GLT-1 transporter activities may resuit in transduction of intracellular
signal MAP kinase activation via N-terminal interacting proteins such as Ajuba (Marie
et al., 2002). Many proteins found at synaptic terminais contain sequences of PDZ
motifs {(PSD-95/SAP9O, discs large (Dig-A, a Drosophila melanogaster protein found
at the separate junction), and Zona occlztdens (ZO- 1, a vertebrate protein found at
epitheliai ce!! junctions)} at the C-termina! end of their sequences, a motif known to
function in interaction of other post synaptic density proteins. With its differing C-
terminai segment containing PDZ sequences. GLT-lv may also interact with the post
synaptic density (PSD) element via c-kinase-] -interacting protein FIcK-] (Chen and
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Rosenberg, 2002). With the possible existence of a nove! synaptic neuronal transporter
(Danbolt, 2001), as well as the fact that GLT-lv interacts with PICK-1, it is tempting
to consider the possibility of this novel spiice variant being GLT-lv. At present, the
protein expression of GLT-lv with light rnicroscopy shows a pattem of astrocytic
staining (Reye et al., 2002; $ullivan et al., 2004) as does mRNA expression with the
exception of few subsets of neurons in layer VI of cerebral cortex and CA3 subfield of
hippocampus (Chen et al., 2004; Berger et al., 2005). Furthermore, the localization of
GLT-lv may be further away from the synapse (Sullivan et al., 2004), suggesting
there may be another as yet unidentified synaptic transporter. The PDZ sequences at
the C-terminal region of GLT-lv suggests the possibility of different regulatory
control of this spiice variant form of GLT- I a, or perhaps a different subcellular
localization to GLT-la (Sullivan et al., 2004).
1.3.3. EAAT4, a glutamate transporter with chloride channel-like properties
EAAT4 displays higher affmity for L-glutamate (K1 = 3.3 ± 0.4 cM) with a
thermodynamically uncoupled chloride conductance, initially cloned in human
cerebellum (Fairman et al., 1995) and later showed to be localized in soma and
dendrites of Purkinje neurons in the molecular layer of the cerebellum (Dehnes et al.,
1998; Yarnada et al., 1996; Nagao et al., 1997). EAAT4 is probably the predorninantly
expressed neuronal glutamate transporter in the Purkinje cells of cerebellum, with an
average density of about 1800 transporter molecules per im2 of spine membrane
(Dehnes et al., 1998). Unlike other glutamate transporters expressed in the cerebellum,
EAAT4 is unevenly expressed in different parasagittal zones with a pattern of
expression resembling that of zebrin (aldolase C, Dehnes et al., 1998), but the
significance of this distinct pattern of expression is not well understood. In the
cerebral cortex, neuronal expression of EAAT4 has also been reported (Massie et al.,
2001).
There now exists several unes of evidence for an astrocytic expression of
EAAT4 in the brain. For example, furuta et al (1997) mentioned sorne astrocytic
labeling in the hippocampus, whereas Hu et al (2003) demonstrated the presence of
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EAAT4 mRNA and protein in cultured astrocytes and mouse spinal cord and, to a
lesser extent, in the forebrain region. In the retina, sorne immunohistochemical reports
suggest EAAT4 is present in the astrocytes (Ward et al., 2004; Fyk-Kolodjief et al.,
2004), while in others no such astrocytic labeling was observed (Pignataro et al.,
2005). Clearly further investigation is required to properly address this matter.
1.3.4. Glutamate transporters in brain trauma and neurologîc disease
A few studies have consistently shown that glutamate transporters may play a
role in excitotoxicity that develops following TBI. In traumatic spinal cord injury,
glutamate uptake activity in synaptosomal preparations was reduced following the
injury, along with 4-hydroxynonenal accumulation that appeared to contribute to
inhibition of glutamate uptake (Springer et al., 1997). Transient downregulation of
GLT-1 and GLAST levels were reported in the ipsilateral cerebral cortex following
controlled cortical impact, with a concomitant reduction in [3H]-D-aspartate binding
activity (Rao et aI., 1998). Other studies have demonstrated a similar downregulation
of GLT-1 and GLAST levels in the ipsilateral and contralateral cerebral cortex, with a
rise in CSF glutamate levels, reaching a maximum at 48 h following the injury (van
Landcghem et al., 2001). In addition. GLU-1 antisense infusion exacerbated neuronal
loss exarnined at 7 days following TBI (Rao et al., 2001e). These resuits suggest
impairment of transport uptake could follow injury due to downregulation of
glutamate transporters that may be partly responsible for the neuronal loss via
secondary excitotoxic mechanisrns. In addition, accumulation of Na and decreased
levels of K in post-traumatic tissue (Soares et al., 1992) further indicate a loss in the
Na7K gradient and hence dirninished glutamate transport capacity, a possible early
consequence 0f TBI.
Following an ischemic insult to the brain, protein levels of glutamate
transporters change in a manner that may contribute to delayed neuronal cell death.
One study that has provided evidence on the relative rote of glutamate transporters in
cerebral ischemia was published by Rao et al (200 la). In this report, infusion ofthe rat
with GLT-1 antisense oligonucleotides prior to the generation of transient cerebral
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ischemia exacerbated the injury, supporting the notion that maintaining the
physiological level of transporter is crucial in minimizing the infarct size. Glutamate
transporters have also been reported to reverse direction in the complete absence of
energy (Rossi et ai, 2000). This condition may 5e confined to the infarct core where
perfusion is sub-ischemic level. In the peri-infarct area, however, downreguiation of
glutamate transporters level may contribute to additional impairment of glutamate
transport. On the other hand, EAACI appeared not to contribute to the outcome of
injury since antisense infusion did not signfficantly exacerbate the ischemic infarction
(Rao et al., 2001d).
Following 2h of focal ischemia, [3H]-D-aspartate binding in the ischernic core
decreased maximally by 20%, reflecting decreased levels of GLT-1 (Gomi et al.,
2000). In another study, the transient focal ischemia in spontaneously hypertensive
rats lead to decreased GLT-1 and EAAC1 protein and messenger RNA levels, but not
GLAST (Rao et al., 20015).
Following transient forebrain ischemia in rats, quantitative immunoblotting
using an antibody against GLT-1 showed a modest 20% decrease in GLT-1 protein
content in the hippocampus 6 hours afier reperfiision (Torp et al., 1995). In situ
hybridization revealed decreased GLT-1 messenger RNA signal rnainly in the CAl
region of hippocampus that became more pronounced at 24 hr (Torp et al., 1995),
suggesting that the down-regulation of glutamate transporters may 5e one of several
factors that contribute to the high sensitivity of CAl pyramidal celis to post-ischemic
damage. In another study, Bruhn et al. (2000) showed conflicting resuits where GLT-1
messenger RNA in CAl and CA3 were decreased but the protein levels were
unchanged in CAl and upregulated in CA3 when investigated using quantitative
irnrnunohistochemistry. Gottlieb et al (2000) also showed increased EAACY levels in
the CAl region with insignificant changes in GLAST and GLT-l levels by combined
techniques of immunoblotting and irnmunohistochemistry following transient cerebral
ischemia in Wistar rats. On the other hand, Rao and colleagues (2000) reported a
transient decrease in hippocampal GLT-1 with progressive loss of hippocampal
EAACY levels and a transient loss of cerebrai cortex EAAC-i levei following
transient forebrain ischemia in the gerbil. These variations in results are iikely due to
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differences in the duration and severity of ischemia i.e. the tirne of artery occlusion
along with the species differences which together contribute to the heterogeneity of
resuits. In summary, therefore, cerebral ischemia may result in down-regulation of one
or more glutamate transporters, thus increasing the vulnerability of surrounding
neurons to excitotoxicity (Danbolt, 2001).
In amyotrophic lateral scierosis (ALS), alterations in glutamatergic
neurotransmission were initially reported (Rothstein et al., 1990, 1992) that were
subsequently linked to a ioss of EAAT2 in the brain and spinal cord of these patients
(Rothstein et al., 1995), a feature of the resulting motor neuron degeneration. The
splice variant GLT-lv is interestingly upregulated in ALS, whereas the opposite is
observed in Huntington’s disease (Maragakis et al., 2004). Recent studies have
demonstrated that overexpression of EAAT2 in mice containing an additional
Cu2/Zn2 superoxide dismutase ($OD1) mutation known to result in this ALS-like
disorder produced a delay in onset of the condition (Guo et al., 2003). However, these
animais did eventually develop the disorder, suggesting that loss of EAAT2 is a likely
contributor to, but not the cause of, neuronal damage. Loss of glutamate transport,
EAAT2, and splice variants of this transporter have also been described in
Alzheimer’s disease (Masiiah et al., 1996; Li et al., 1997), in experimental
Huntington’s disease (Behrens et al., 2002), and in a model ofthe Guamanian disorder
AL$-parkinsonism dementia complex (Wilson et ai., 2003).
1.4. Introduction to complexins: expression, localization and mechanism of action
As mentioned earlier, the glutamate rise following an insuit to the brain could
originate from different sources (Figure 1.3). In a glutamatergic synapse, for example,
increased presynaptic release owing to the rise in one or severai constituents of
exocytotic machinery could lead to increased extrasynaptic glutamate. In the following
section, presynaptic proteins termed complexins will be introduced, along with the
explanation of its importance on molecular machinery of exocytosis and its potential
role in neurodegenerative disease.
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1.4.1. Role of complexins in the molecular mechanism of neurotransmitter release
Complexins are 15-16 kDa cytosolic proteins. In the cerebrai cortex and
hippocampus, electron microscopic studies have shown that compiexin I (aiso known
as synaphin II) is found in axosomatic terminais and compiexin II (aiso known as
synaphin I) in axodendritic terminais (Ishizuka et al., 1999). This iocalization of each
compiexin to presynaptic neurons of inhibitory and excitatory synapses has permitted
differentiai assessment of excitatory and inhibitory pathways (Harrison and Eastwood,
199$; Eastwood et ai., 2001). Both compiexins show highiy conserved sequence
homology between species, with 100% homoiogy between rat, mice and human
compiexin II (McMahon et al., 1995). Complexins are thought to compete with the
chaperone protein a-$NAP (soluble N-ethylmaleimide-sensitive factor-attachrnent
protein) for binding to SNAP receptors (SNAREs) at the presynaptic terminai
(McMahon et al., 1995). These $NAREs consist of the synaptic vesicle protein
synaptobrevin as well as the synaptic membrane proteins $NAP-25 and syntaxin 1
(Figure 1.6). Further studies have indicated that complexins rapidly bind to the
SNARE complex in an anti-paraliel configuration and with high affinity (Pabst et al.,
2002; Chen et ai., 2002), stabilizing the fuliy assernbled $NARE complex. This key
step enabies the rapid Ca2-evoked neurotransmitter release (Chen et al., 2002),
promoting interaction of transmembrane region between v-SNARE
(synaptobrevinlVAMP) and t-$NARE (SNAP-25) and thereby facilitating neuronal
exocytosis (Ru et al., 2002). However, the exact contribution of compiexins to
neurotransmitter release has been a controversial issue, with some studies indicating
that complexins play a negative role in exocytosis, and others suggesting a positive
role in neurotransmitter release (Ono et al., 199$; Tokurnaru et al., 2001; Reim et al.,
2001).
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Figure 1.6. Simplified diagram depidfing synapflc vesicle in proximlly
to flic plasma membrane.
Complexins are thought to play a negative role in exocytosis by competing
with Œ-SNAP (McMahon et al., 1995), thereby interfering with dissociation of the
$NARE complex and subsequent recycling ofvesicles required for fiirther exocytosis.
In addition, the finding that injection of an anti-complexin II antibody into presynaptic
neurons of the Aplysia buccal ganglion stimulates neurotransmiller release, whereas
recombinant complexin II bad the opposite effect, suggests a potential inhibitory role
in the exocytosis machinery (Ono et al., 199$). furthennore, over-expression of
complexins in PCI2 ceils resulted in reduced exocytosis of secretory vesicles (Itakura
et al., 1999). However, the dissociation of SNARE complex occurs regardless of
whether complexin is bound or not (Pabst et al., 2000), and a small oligopeptide
specifically dismpting the complexin binding to the $NARE complex showed a
positive role in the molecular machinery of exocytosis (Tokurnam et al., 2001),
supporting an opposite positive role for tins complexin. Indeed, the finding that Ca2t-
dependent synchronous release of neurotransmitter is significantly impaired in double
Complexïn
SNAP-25 jjSYntaxin
z: 1•
t-SNARE Plasma membrane
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knockout mice lacking both complexins (Reim et al., 2001) further supports die notion
that complexins are requircd for synaptic vesicle release.
1.4.2. Role of complexins in neurodegenerative disease
In psychiatric disease such as major depression, bipolar disease and
schizophrenia (Sawada et al., 2002; Eastwood and Harrison, 2001), complexin levels
have been measured in post-mortern brain tissue in order to assess the extent of
excitatory or inhibitory involvement in the region of interest. Moreover, in a
transgenic mouse model ofHuntington’s disease, progressive loss ofcomplexin II was
detected that later colocalized in a subpopulation of neuronal intranuclear inclusions
with ubiquitin (Morton and Edwardson, 2001). In addition, expression of mutant
Huntingtin, the gene responsible for Huntington’s disease, blocked exocytosis in PC12
celis via depleting complexin II levels, which could be rescued by overexpressing
complexin II in the same celis (Edwardson et al., 2003), indicating the potential
importance of this novel presynaptic protein in neurodegenerative disease states. Thus
far. studies have flot yet been published on the potential involvement of complexins in
brain injury such as stroke or TBI, making such an investigation of the role of
complexins in excitotoxicity of particular interest.
1.5. General mechanisms of oxidative injury after TBI
Oxidative stress has been defined as a disturbance in the pro
oxidant/antioxidant balance in favor of the former, leading to potential damage (Sies,
1991). Natural formation of oxidants during mitochondrial electron transport, auto
oxidation of some neurotransmitters such as norepinephrine or doparnine, and
initiation of events during trauma, hypoxia or ischemia, can result in oxidant
formation and subsequent tissue damage (Warner et al., 2004).
Oxidative stress can be traced primarily to formation of superoxide and nitric
oxide. Superoxides are mostly generated from electron leak during mitochondrial
electron transport, perturbed mitochondrial metabolism and inflarnmatory responses to
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injury (Halliweil and Gutteridge, 1999), whereas nitric oxides formation is both
constitutive and inducible. Brain injury-induced nitric oxide overproduction is in part
caused by glutamatergic-mediated increases in intracellular calcium concentration,
resulting in a calmodulin-dependent upregulation of nitric oxide synthetase
(Garthwaite et al., 198$).
Nitric oxides can elicit nitrosative damage (Espey et al., 2000) via independent
nitrosylation of protein heme sites or through its reaction products with oxygen or
other nitrogen oxides (Warner et al., 2004). The major oxidative stress produced by
excessive nitric oxides is its reaction with superoxide to resuit in peroxynitrite
formation (Beckman et al., 1990) and its involvernent in the Fenton reaction (Warner
et al., 2004). An example ofperoxinitrite-associated damage ofprotein function would
be its reported action on inhibition of glutamate transporter (Trotti et al., 1996).
Superoxides can also cause oxidative damage of iron!sulfur clusters of aconitase
(Gardner and fridovich, 1991), an important enzyme in the tricarboxylic acid cycle.
Hydroxyl radical, peroxinitrite and peroxinitrite-derived products all have the potential
to react with and damage rnost cellular targets including lipids, proteins and DNA. As
such, reactive oxygen species/nitrosative species have been most commonly tracked
by measuring stable metabolites such as nitrates/nitrites or footprints of the reactions
of these molecules with lipids (thiobarbituric acid adducts, 4-hydroxinonenal), DNA
($-hydroxyguanine), or proteins (nitrotyrosine).
1.5.1. Role of antioxidants in TBI
The brain has potent defenses against superoxides such as endogenous
tripeptide glutathione and enzyrnatic antioxidants superoxide dismutases or Catalases.
These antioxidants regulate superoxide concentration by dismutation of superoxide to
hydrogen peroxide (superoxide dismutase) which is then converted to water
(peroxidases such as glutathione peioxidase and peroxiredoxin) or dismuted to water
and oxygen (Catalase, see Warner et al., 2004). Although these antioxidants are
reported to be up regulated following brain injury, endogenous antioxidant capacity
can be overwhelmed, leading to increased superoxide and hydrogen peroxide
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concentration (Warner et al., 2004), and exogenous application of antioxidants
following experimental TBI have shown its beneficial effect in minimizing the injury
volume and neuronal loss post trauuma.
Ates and colleges (2006) have tested the effect of antioxidant Resveratrol on
traumatized rats using weight drop mode!. They showed that the trauma caused a
significant increase in Malondialdehyde (MDA), Xathine oxidase (XO), nitric oxide
levels and decrease in glutathione level as compared to control group. Resveratrol
administration significantly reduced MDA, XO and nitric oxide levels, increased GSH
level, and also attenuated tissue lesion area. In another study, pre-treatment with
LY341 122 (a potent inhibitor of lipid peroxidation and an antioxidant) attenuated
histopathological damage, as indicated by smaller contusion volumes and a reduction
in damaged cortical neurons after fluid percussion brain injury in rats (Wada et al.,
1999). Stilbazulenyl nitrone, a novel antioxidant, has been shown to improve
neurological deficit and reduce histopathological damage afier TBI (Belayev et al.,
2002).
Bromocriptine, a dopamine D2 receptor agonist with significant antioxidant
properties, was tested on cognition, histopathology, and lipid peroxidation in a rodent
model of focal brain trauma. Bromocriptine-treated group was signiflcantly more
adept at locating a hidden platforrn in the water maze cornparcd to the vehicle group
and also exhibited a greater percentage of surviving CA3 hippocampal neurons
following TBI (Kline et al., 2004). In addition, a well-known antioxidant N
acetylcysteine (NAC) was effective in reducing the injury volume afier TBI via its
antioxidant-capacity. NAC treatment also attenuated the induction of antioxidant
protein herne-oxygenase-I in astrocytes following TBI (Yi and Hazell, 2005)
1.5.2. N-acety]cysteine and brain injury
NAC is a cysteine analogue antioxidant (glutathione precursor) with multi
therapeutic uses and is commonly used to treat the hepatotoxic consequences of
acetaminophen overdose (Kelly, 1998). NAC can protect against reactive oxygen
36
species-induccd injury either by promoting glutathione synthesis (Corcoran et al.,
1986) or by direct scavenging action (Aruoma et al., 1989).
NAC treatment (163mg/Kg, i.p.) given within 1 h post-T3I greatly restored
brain and brain mitochondrial glutathione levels (Xiong et al., 1999). The treatment
also rnarkedly restored mitochondrial electron transfer, energy coupling capacity,
calcium uptake activity and reduced calcium content absorbed to brain mitochondrial
membranes when examined post-TBI. This study suggests that NAC adrninistered at
an early stage post-injury can cffectively attenuate TBI-induced mitochondrial
dysfiinction, and this protective effect of NAC may be related to its restoration of
glutathione levels in the brain. Same authors also reported later on that NAC
adrninistered afler severe CCI reduced appearance of shortened BC1-2 and BAX
proteins, suggesting anti-apoptotic effect ofNAC (Xiong et al., 2001).
NAC at 163 rng/kg has previously been shown to enhance hippocampal
neuronal survival aller transient forebrain ischemia in rats (Knuckey et al., 1995), and
same dose was reported to restore cerebrovascular resposiveness following traurnatic
brain injury in cats (El lis et al., 1991).
In neonatal rats, the combined treatment of NAC and hypothermia attenuated
hypoxic-ischernic injury (Jatana et al., 2006). Cuzzocra and colleges (2000) have
reported that NAC treatment resulted in reduced ederna index and attenuated
myelopeoxidase formation as well as reducing NT positive staining resulting in
increased survival and reduced hyperactivity following MCAO in Mongolian gerbils.
However, when dogs were subjected to global ischernia induced by cardiac
arrest, NAC did not show any neurological score improvernent ($ilbergleit et al.,
1999). In addition, Thomale and colleges have used the same amount of NAC
(163mg/Kg, i.p.) given aller CCI of moderate severity and showed that there were no
significant differences in the ICP, brain edema as well as the size of the contused
volume in rats (2006). Using a single clip spinal cord model in rats, NAC showed no
MDA content change after 1h (Kaynar et al., 1998). It is likely that sorne differences
may exist between varying models, animais, conditions of the study, as well as the
person conducting the study.
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1.6. Thesis objectives
Elevated levels of glutamate following brain trauma exert thefr effect via
excitotoxic mechanisms and perturbation in ionic gradients across the ceil membrane.
This constftutes one of the major secondary injuries following TBI. However, the
precise mechanism(s) by which this increase occurs foïlowing TBI is stiil unknown,
with different potential routes suggested (Figure 1.3).
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This thesis will investigate the possibility that glutamate transporters and
complexins contribute to elevated levels of glutamate following FPI. This will be
achieved by formulating and testing two hypotheses: 1) Alterations in glutamate
transporter subtypes occur following TBI that may contribute to the increased
glutamate and neuronal loss, and 2) TilT produces changes in complexin levels that
may contribute to increased release of neurotransmitters and excitotoxic damage
(figure 1.7).
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CHAPTER 2
EXCIT0TOMC MECHANISMS AND THE ROLE 0F GLUTAMATE
TRANSPORTERS IN THE PATHOPHYSIOLOGY 0F TRAUMATIC BRAIN
INJURY
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2.1 Article 1
Early loss of the glutamate transporter splice variant GLT-lv in rat cerebral
cortex following lateral fluid-percussion injury.
Glia 49(1), 121-133 (2005)
Jae-Hyuk Yi, *David V. Pow, and Alan S. Hazeli
Department of Medicine, Hôpital Saint-Lue, University of Montreal,
Montreal, Quebec, Canada; *Departrnent of Physiology and Pharmacology, University
of Queensland, Brisbane, Australia
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ABSTRACT
Glutamate transporter proteins are essential for the control of interstitial
glutamate levels, with an impairment oftheir ftinction or levels being a major potential
contributor to excitotoxicity. We have investigated the effects of lateral fluid
percussion on the levels of the glutamate transporter proteins GLT- 1 a, its spiice
variant GLT-lv, GLAST, and EAAC1 in the rat in order to evaluate their pathogenetic
role in this model of traumatic brain injury (131). Immunoblot analysis revealed
neuronal loss in the cerebral cortex was accornpanied by a 54% decrease in GLT- 1v 6
hr following the insuit which progressed to an 83% loss of the transporter after 24 hr.
No changes in GLT-la, GLAST or EAAC1 were observed in this brain region at
either time point. GLT-lv content was also decreased by 55% and 68% in the
hippocampus and thalamus respectively at 6 hr post-injury, but recovered fully after
24 hr in both brain regions. In contrast, levels of GLT-IŒ were increased in the
hippocampus at 6 br and 24 hr post-TBI. These alterations in transporter protein
content were also confirmed using immunohistochemical methods. Our resuits show
for the first time a pattern of early, dynamic changes in the levels of GLT- 1 transporter
spiice variants in different brain regions in this trauma mode!. In addition, correlation
of GLT-lv levels with both neuronal ce!! loss and a-internexin content in the injured
cortex suggests that loss of this novel glutamate transporter may be a key factor in
determining cerebral vulnerability following this type of brain injury.
Running titie: GLT-1 transporters and TBI
Keywords: traumatic brain injury, glutamate transporter, excitoxicity, GLT-1, fluid
percussion
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INTRODUCTION
Glutamate excitotoxicity plays a crucial role in the secondary damage caused
by traumatic brain injury (TBI), in which increased glutamate concentrations in the
extracellular fluid have been reported (Katayama et al., 1990; Zauner et al., 1996;
Koizurni et al., 1997; Matsushita et al., 2000). The neurotoxic effect of extracellular
glutamate is well documented (Di et aI., 1999; Choi, 1992; Clausen and Bullock,
2001), in which over-excitation by glutamate can lead to subsequent neuronal loss.
Our understanding of the exact mechanism by which increased levels of glutamate in
the interstitial cornpartrnent can cause excitotoxic damage continues to evolve, with
recent studies reporting that administration of NMDA receptor antagonists such as
mernantine, phencyclidine or MK-80 1 exert a protective effect following TBI (Hayes
et al., 198$; Mclntosh et al., 1989; Okiyarna et al., 199$; Rao et al., 2001b),
supporting the notion of a glutamate-mediated process in this disorder.
Clearance of extracellular glutamate is mainly executed by astrocyte glutamate
transporters. The concentration of extracellular glutamate necessary for neurotoxicity
in cultured neurons increases substantially when astrocytes are added (Nichoils and
Attwell, 1990), providing evidence that astrocytic glutamate transporters play an
important role in the clearance of this arnino acid. In addition, antisense knockdown
studies reveal that GLA$T and GLT-1, but flot EAAC1, produce excitotoxic damage
and increased susceptibility to seizures and injury (Rothstein et al., 1996; Tanaka et al.,
1997; Rao et al., 200 lc,d), with a body of evidence supporting an important role of
astrocytic glutamate transporters in a variety of brain disorders that include ischemia,
thiamine deficiency, amyotropic lateral sclerosis, acute liver failure, and Alzheimer’s
disease (Rothstein et al., 1995; Torp et al., 1995; Knecht et al., 1997; Li et al., 1997;
Hazeli et al., 2001). In brain, five subtypes of glutamate transporter have so far been
cloned: GLAST (Stork et al., 1992), GLT-1 (Pines et al.. 1992), EAACY (Kanai and
Hediger, 1992), EAAT4 (fairmen et al., 1995) and EAAT5 (Arriza et al., 1997). 0f
these, GLAST and GLT-1 are predominantly localized in astrocytes (Danbolt et al.,
1992; Rothstein et al., 1994; Lehre et al., 1995), while EAAC-1, EAAT4, and EAAT5
appear to be mainly neuronal. Previous studies have indicated that GLT-1 and GLA$T
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levels are decreased following cortical impact injury (Rao et al., 199$; van
Landeghern et al., 2001), and that intracortical infusion of glutamate or knockdown of
GLT-1 by antisense oligonucleotides exacerbates TBI (Di et al., 1999; Rao et al.,
2001c). Reports of the existence of alternative GLT-1 sequences (Utsunorniya-Tate et
al., 1997) have been followed by studies involving a spiice-variant known either as
GLT-lv (Schrnitt et al., 2002) or GLT-1B (Chen et al., 2002; Reye et al., 2002). Since
this GLT- lB variant form is different to a GLT- 1 B form described by Utsunorniya
Tate and colleagues, we will use the terrn GLT-lv in subsequent references to this
protein to avoid confusion, and GLI- 1 Œ to refer to the original spiicing forrn of GLT- 1
(Sullivan et al., 2004). GLT-lv appears to be predominantly localized to astrocytes
rather than neurons (Reye et al., 2002) but has also been reported in neurons and
microglia (Schmitt et al., 2002; Chen et al., 2002). While the importance of GLT-1
(GLT-IŒ and GLT-lv) in the clearance of glutamate is well established (Rothstein et
al., 1996), where its activity accounts for -90% of glutamate uptake (Kanai, 1997). the
impact of GLT-lv alone on cerebral disorders remains largely unknown.
In the present study, we investigated early effects of TBI in rats following
lateral fluid-percussion, a clinically relevant model of TBI that reproduces many of the
key pathophysiological features exhibited in head-injured patients (Mclntosh et al.,
1989). Using specific antibodies directed against GLASI, GLT-1Œ, EAAC1 and GLT
1v in association with immunoblotting and irnrnunohistochemistry, levels of these
transporters were evaluated in relation to neuronal damage in the injured cerebral
cortex, hippocampus, and thalamus. Our resuits suggest an important role for GLT-lv
in the sequetae of events following 131.
MATERIALS AND METHOUS
liaterials
Protease inhibitor cocktail, mouse monoclonal antiserum to r3-actin, rabbit anti
goat IgG secondary antibody, 3,3’-diaminobenzidine (DAB), nickel ammonium
sulfate and sodium azide were purchased from Sigma Chernical Co (St. Louis, MO,
USA). Polyvinylidene difluoride (PVDf) membranes and broad-range protein markers
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were purchased from Bio-Rad Laboratories (Hercules, CA, USA), enhanced
chemilurninescence (ECL) kits were purchased from New England Nuclear (Boston,
MA, USA) and X-OMAT autoradiography film was purchased from Kodak (11e des
Soeurs, Quebec, Canada). Affinity-purified goat polyclonal antisera to guai fibrillary
acidic protein (GfAP), to a-internexin, and to synaptophysin, biotinylated donkey
anti-rabbit and donkey anti-goat IgG secondary antibodies were purchased from Santa
Cruz Biotechnoiogy, Inc ($anta Cruz, CA, USA). Affinity-purified mouse monoclonal
antiserum to glutamine synthetase (GS) was purchased from BD Biosciences
Pharmingen (San Diego, CA, USA). HRP-coupled goat anti-rabbit and goat anti
mouse IgGs were purchased from Promega (Madison, WI, USA). HRP-coupled
donkey anti-goat IgG was purchased from Prornega Corporation (Madison, WI, USA).
Trauma Mode!
The lateral (parasagittal) model of traurnatic brain injury used in this study bas
previously been described in detail (Mclntosh et al., 1989). Ail procedures were
undertaken with the approval of the Animal Ethics Committee of Hôpital Saint-Luc
and the University of Montreal, and were conducted in accordance with the guidelines
set out by the Canadian Council on Animal Care. Male Sprague-Dawley rats weighing
350-375 g were housed under constant conditions oftemperature, humidity and 12:12
h day/night cycle, and fasted overnight. The following day, animais were injected witb
sodium pentobarbital, (65 mg/kg, i.p.) and placed in a stereotaxic frame. A 4.8 mm
diameter craniotomy, centered between bregma and lambda, and 2.5 mm lateral to the
superior sagittal sinus was made over the lefi hernisphere using a trephine drill, and a
hollow female Luer-Lok fitting secured with dental cernent. Rats were subsequently
allowed to recover overnight and, the following day, reanesthetized with 2%
isofluorane and exposed to lateral fluid-percussion injury ofmoderate severity (2.0-2.5
atrn). The pressure wave applied was recorded using custom-written software (FP302;
ArnScien Instruments, Richmond, VA, USA) to monitor reproducibility. All animais
recovered from transient apnoea with good peripheral circulation within 45 sec of
injury. Sham controls received identical treatrnent but without exposure to trauma.
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Inimtt;iobtottiiig
At the appropriate time, a total of 17 rats (shams, n 5; 6 hr post-TBI, n 6;
24 br post-TBI, n = 6) were sacrificed by decapitation. The brains were removed and
rapidly frozen in isopentane at -20°C. Regions of interest (injured cerebral cortex,
hippocampus, and thalamus) were dissected out at 0°C over dry ice in a coronal block
of tissue extending -3.8 to -5.8 mm from bregma (Figure 1). Tissues were
homogenized in ice cold TE buffer (5OmM Tris, 1 50mM NaCI) with protease inhibitor
cocktail (Sigma Chemical Co., St. Louis, MO, USA) and phenylmethylsulfonyl
fluoride (PMSF) using a Teflon glass hornogenizer at 1000 rpm, 25 strokes, on ice.
Resulting homogenates were centriftiged for 30 min at 15 000 x g, 4°C, and the
supematants designated “crude cytosolic fraction” were separated into another tube.
Pellets were washed with TE buffer, recentrifuged, the supernatant discarded, and
solubilized in RIPA buffer (50 mM Tris, 150 mM NaC1, 0.1% SDS, 1% NP-40, 0.5%
sodium deoxycholate, pH 8.0 and protease inhibitor cocktail). The latter were
designated “crude membrane fraction”. Protein content was determined by the method
ofLowry et al (1951).
Immunoblotting assays were performed as previously described (Hazell et al.,
2001). Briefty, aliquots of the crude membrane fraction were added to equal volumes
of sample buffer containing dithiothreitol (200 mM) and proteins were separated using
discontinous SDS-polyacrylamide gel electrophoresis (SDS-PAGE) consisting of 10%
resolving and 4% stacking gels at a constant 40 V overnight and transferred to PVDF
membranes by wet transfer. Membranes were subsequently incubated in a blocking
solution consisting of 5% dry non-fat milk in TTB$ (lOmM Tris, lOOmM NaC1, and
0.1% Tween-20) followed by incubations with antisera against GLT-la (1:10,000),
GLT-lv (1:1,000), GLAST (1:5,000), EAAC1 (1:1,000), a-internexin (1:1,000),
synaptophysin (1:200) or actin (1:10,000) in blocking solution for 1 hr, washed tbree
times in TTBS, and then reblocked for 45 min. Details of characterization of rabbit
polyclonal antisera to the C-terminal domains of GLT-lv, GLAST and GLT-la have
previously been described (GLT-la and GLT-lv, Reye et al., 2002; GLAST, Pow and
Barnett, 1999). The antibody against GLT-lv was raised using the synthetic peptide
PFPFLDIETCI corresponding to the carboxyl terminus of GLT- 1v in mouse (Genbank
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accession number NP035523) (Utsunomiya-Tate et al., 1997) and the sarne carboxyl
terminus region in rat (Chen et al., 2002; Schmitt et al., 2992). A gifi of rabbit
polyclonal antiserum against EAAC 1 (C-491) was kindly provided by Dr. Niels
Danbolt. In some cases, incubation with primary antisera was performed at 4°C. Afier
further washes in TTBS, membranes were incubated in HRP-coupled goat anti-rabbit
(1:20,000), goat anti-mouse (1:20,000), or donkey anti-goat IgG (1:20,000) secondary
antiserum in blocking solution for 1 hr. Membranes were then washed five times with
TB S, trcated with ECL kit reagents according to the manufacturer’ s instructions and
then exposed to X-OMAT film. Optical density measurements were performed using a
microcomputer-based image display system (Imaging Research Inc., St. Catherines,
Ontario, Canada). Linearity of the relationship between optical density and protein
concentration was verified using appropriate standard curves. Coornassie staining of
the acrylamide gels was performed to ensure equal loading ofproteins.
Irnrnunohistocliemistry t’uzd Histology
Rats (ail groups, n 4) were deeply anesthetized with pentobarbital (60 mg/kg)
and perfused transcardially as described previously (Hazell et al., 2001). Brains were
removed and post-fixed overnight in neutral-buffered formalin containing 4%
formaldehyde, 0.5% sodium phosphate buffer, and 1.5% methanol, pH.7.O. Coronal
sections (-3.8 to -5.8 mm relative to bregma) of 40-pin thickness were eut using a
vibrotorne according to the rat brain atlas of Paxinos and Watson (1998).
Immunohistochemistry was performed according to Hazeli and colleagues (2001).
Briefly, sections were incubated for 10 min in phosphate-buffered saline (PB$)
containing 0.3% hydrogen peroxide to block endogenous peroxidase activity. Tissue
sections were then washed in PBS (3 x 10 mm), blocked for 20 min in 0.5% Triton X
100 and 5% donkey serum, and incubated with or without 0.5% Triton X-100, along
with 5% donkey serum and primary rabbit antisera directed against GLT-1Œ (1:1,000),
GLT-lv (1:500), GLAST (1:400), or EAACY (1:1,000), goat-derived antisera against
Œ-internexin (1:250) or synaptophysin (1:100), or mouse-derived antisera against
GFAP (1:1,000) or GS (1:5,000) at 4°C for 24 hr. The following day, sections were
washed (3 x 10 mm) and incubated for 1 hr with biotinylated donkey anti-rabbit/goat
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IgG in P55 containing 0.5% Triton X-100 followed by washing (3 x 10 mm), and
incubation for 1 br in streptavidin-HRP conjugate in PBS with 0.5% Triton X-100.
Sections were then again washed (3 x 10 mm), followed by incubation with DAB
(0.05%) in PBS containing 25 rng/ml nickel ammonium sulfate for signal
enhancement and in the presence of H202 (0.03%) for 2-10 minutes. Sections were
then mounted on Superfrost Plus slides (Fisher Scientific, Ottawa, Ontario, Canada),
cleared in xylene, and coverslipped with permount. Negative controls consisted of
omission of primary or secondary antibody, resulting in loss of immunoreactivity.
Vibratome-cut sections were stained with cresyl violet for evaluation by light
microscopy. Neuronal celi numbers were assessed by counting and averaging four
adjacent grid areas (0.06 mm2 each) at a magnification of400X.
RESULTS
Irninunoblot stttdies on glutamate traitsporters
Levels of the glutamate transporters GLT-1Œ, GLT-lv, GLAST, and EAAC1
were studied in brain regions with known vulnerability to damage in this model by
immunoblotting. In the injured cerebral cortex, a decrease in GLT- 1v was observed at
6 hr and 24 hr following TBI which was not apparent in the case of GLT- 1 Œ, GLAST,
or EAAC1 (Fig. 2A). Quantitative analysis revealed that, relative to actin content,
GLT-lv levels were decreased by 54% (p <0.01) compared to shams 6 hr following
injury, and further reduced by 83% (p <0.01) afier 24 hr (Fig. 2B). Both GLT-lv and
GLT- 1 x blots exhibited bands corresponding to monomer and multirner forms of the
transporter proteins. In quantitating the levels of these two transporters, we considered
both monomer and multimer forms of the proteins. However, the multimer bands
showed no obvious differences between sham and TBI groups (data not shown).
Examination of the hippocampus and thalamus revealed that levels of GLT-lv
were transiently reduced by 55% and 68% (p <0.01) respectively 6 hr following TBI
(Fig. 3A,B). However, GLT-lv levels retumed to normal 24 br post-injury in both
areas. Interestingly, in the hippocampus, the decrease in GLT-lv 6 hr post-TBI was
accompanied by an increase in the levels of GLT-la (40%, p < 0.05) that was also
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present at 24 lirs following trauma (57%, p < 0.05) (fig 3A,B). However, this effect
on GLT- 1 Œ was flot evident in the thalamus. In contrast, GLAST and EAAC 1 levels
wcre found to be unchanged in both the hippocampus and thalamus (data flot shown).
Histotogicat Anatysis
Histofogical assessment fol lowing cresyl violet staining revealed considerable
damage to the affected portion of the cerebral cortex (area directly below the site of
trauma, f ig. 1), particularly in the deeper layers, associated with a loss ofneurons 6 hr
following induction of TBI (Fig. 4A-C). further loss of neuronal staining and the
presence of gliosis were observed afler 24 hr in this area. In the hippocampus, damage
was rnost evident in the stratum pyramidale of the CA2 subfield, at 6 hr and 24 hr
following trauma (Fig. 5G-I). Neuronal damage was also observed as early as 6 hr
following TBI in the stratum granutosum of the dentate gyrus, stratum pyramidale of
the CAl region, and in the posterior lateral and lateral ventral thalamic nuclei.
Quantitatively, in the 6 hr post-TBI group, decreases in neuronal celi numbers of 47%,
40%, and 41% compared with shams were observed in the cortex, hippocampus, and
thalamus, respectively (Table 1). Twcnty four hours following TBI, animals showed
further decreases in neuronal cell numbers of 76%, 64%, and 66% in these three brain
regions (Table 1).
Irnmunohistochemistry
Examination of GLT-lv immunoreactivity in the injured cortex revealed a
considerable loss of immunoreactivity, particularly in layers V and VI that seerned to
coincide with the area where most of the damage was observed (Fig. 4D-F).
Immunolabeling appeared to be “patchy” in the other layers. In the hippocampus and
thalamus, loss of immunoreactivity was transient (Fig. 4G-f,J-L), with the loss of
irnmunoreactivity occuring mostly in the perikarya. In the hippocampus, GLT- 1v
immunostaining appeared to be localized to astrocytes (Fig. SA, inset) with decreased
immunoreactivity being evident at 6 hr post-TBI compared to sham controls. Loss of
immunoreactivity was pafflcularly obvious in the stratum radiatum at this time (fig.
5B). On the other hand, GLT-lu irnmunoreactivity was increased afier 6 hr cornpared
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with sham animais and this effect was maintained at 24 hr post-injury (Fig. 5D-F).
GLT-1Œ immunostaining was particulariy high in the CA2 subfield where
considerabie neuronal damage was observed, with intense labeling of astrocytic
processes around the pyramidal ceils (Fig. 5H,I). Comparison of GLT-lv
irnrnunoreactivity with that of the astrocyte-specffic GS and the astrocyte-localized
cytoskeletal protein GfAP revealed a close similarity in labeling patterns in both the
injured cortex and hippocampus (Fig. 6), providing further support of an astrocytic
localization for GLT-lv.
Retatio;iship between GL T-1v and neuronal damage in the injured cerebral cortex
In order to further evaluate the extent of neuronal damage we measured Œ
internexin protein content in the injured cortex by immunoblotting (Fig. 7A). Levels
of a-internexin were decreased by 17% in the 24 hr post-TBI group cornpared to sham
ievels (p < 0.05). In contrast, no changes in synaptophysin ievels were detected in
either the 6 or 24 hr-post TBI groups compared to control rats (data flot shown).
Examination of the relationship between GLT-lv transporter leveis and neuronal
counts showed a significant (p = 0.0001) positive correlation during the first 24 hr
foilowing brain injury (Fig. 7B). Assessrnent of the reiationship between leveÏs of
GLT-lv and Œ-internexin also showed a signfficant (p = 0.0358) positive correlation
during the first 24 br following TBI (Fig. 7C).
DISCUSSION
In this study we have provided the first evidence of aiterations of astrocytic
glutamate transporter ieveis foliowing laterai fluid-percussion injury to the brain.
Figure 8 shows a summary of the present findings. Our resuits indicate a ioss of the
transporter spiice variant GLT-lv, but not GLT-1Œ, in the injured cerebral cortex,
occurring as eariy as 6 hr post-TBI, and which is sustained for up to 24 hr following
the insuit. This is particularly interesting as GLT- 1 is considered to be functionally the
rnost important glutamate transporter subtype in brain, accounting for at least 90% of
the glutamate uptake capacity under normal conditions (Haugeto et al., 1996; Tanaka
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et aÏ., 1997), and comprising activity associated with both GLT-1Œ and the novel
spiice variant GLT-lv. Given the degree of cortical damage that ultimately results
following moderate fluid-percussion injury tRicks et al., 1996), our findings of an
early loss of GLT-lv levels suggest that this transporter is an important pathogenetic
contributor in this brain region. At the sarne tirne, leveÏs of other glutamate
transporters such as GLA$T and the neuronal transporter EAAC- 1 were unaffected in
this brain region, ftirther ernphasizing this issue. These findings with GLT-lv are also
similar to a recent study in which treatrnent of mice with a cycad neurotoxin as a
model of ALS-PDC lcd to levels of GLT-lv being more affected than GLT-la
(Wilson et al., 2003).
Previous studies have reported increases in extracellular glutamate
concentration in the cerebral cortex following IBI (Nilsson et al., 1990; Kanthan and
Shuaib, 1995; Bullock et al., 1998). Although Rao and colleagues (199$) have
reported a downregulation of glutamate transporters (GLT- 1 x and GLA$T) following
brain trauma (Rao et al., 199$), we have been unable to reproduce thcse findings in the
present study. However, this discrepancy may be due to the fact that the Rao study
involved a cortical impact model, which typically causes more damage to the tissue
than in our case. Use of lateral fluid-percussion injury provides a more clinically
relevant model ofbrain injury in terms ofthe mechanical shearing forces developed at
the time of injury (Mclntosh et al., 1989; Hicks et al., 1996), and thus loss ofGLT-lv
but not GLI- 1 Œ and GLAST may be more representative of the consequences of
moderate concussive injury. Our findings of a strong positive correlation between
GLT-lv levels and neuronal counts (r 0.78, p = 0.0001) suggests this glutamate
transporter spiice variant may contribute to ccli death in the injured region of the
cortex. b investigate this further, we used the neurofilament protein Œ-internexin as a
supporting index of neuronal damage. Examination of the reiationship between levels
of GLT-lv and a-internexin revealed a significant positive correlation in the injured
cortex (p 0.03, r = 0.5 1), adding further credence to the concept that loss of this
glutamate transporter plays a role in the neuronal damage to this area. Previous studies
have established that neuronal cell death is associated with decreased levels of this
axonal protein, including loss of Œ-internexin in the spinal cord of patients with
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arnyotrophic lateral scierosis in which motor neurons undergo celi death (Wong et al.,
2000), in post-mortem brain (Fountoulakis et al.. 2001), and in association with
neuroblastoma ce!! death (Chan et al., 199$). Downregulation of GLT-lv may
therefore be a major contributing factor to the rise in interstitia! glutamate !eve!s
observed following the ensuing neurona! damage and ce!l loss. On the other hand, it is
possible that loss of GLT- 1v may be a consequence of the neuronal injury process
itse!f; similar effects have been observed with GLT-1 (Levy et al., 1995). Indeed, the
patchy nature of the GLT-lv iinmunostaining in the injured cortex appears to be
consistent with the pattern of cresy! violet staining of the same area, indicating that
some astrocytes may either be affected by the neurona! damage or may die in this
region. It is also possible that GLT-lv and neurona! ce!! !oss may simpÏy be conelated
with no direct cause-effect re!ationship. Further studies are therefore necessary to
investigate in more detai! the mechanisrns invo!ved in the regulation of this nove!
glutamate transporter spiice variant.
In the hippocampus, GLT- 1v was transiently decreased at 6 hr post-TBI but
recovered to normal values after 24 hr. On the other hand, GLT- 1 a leve!s were
upregulated at 6 hr following TBI and maintained at elevated leve!s up to 24 hr. One
interpretation of these flndings is that hippocampa! astrocytes may be attempting to
compensate for the early loss of GLT- 1v by upregulation of GLT- 1 Œ in order to
maintain adequate remova! of g!utarnate from the extrace!!ular space. Interestingly, the
tha!amus a!so experienced a simi!ar transient decrease in GLT- 1v !evels but without
the accompanying e!evation of GLT- 1 Œ. This is despite the fact that the degree of
neuronal loss experienced in the hippocampus was very similar to that ofthe tha!amus
following TRI. A!though the reason for this interregional difference regarding GLT
1 Œ is unknown, differences in normal excitatory/inhibitory influences or differences in
the leve!s of these two sp!ice variants of GLT-1 between these two regions may
uÏtimately determine the astrocyte response. In addition, studies have demonstrated
that soluble factors re!eased by neurons (Gege!ashvili et al., 1997), possib!y as a
consequence of damage, can upregulate GLT- 1 x; thus reversa! of the downregulation
ofhippocampal and thalamic GLT-Iv levels at 24 hr may be due to a similar process.
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Developing gliosis following neuronal ceil death may also contribute to this later
recovery of GLT-lv.
Whiïe the functional interactions between GLT- la and GLT- lv are presently
unclear, the study by Utsunomiya-Tate and colleagues (1997) using Xenopïts oocytes
demonstrated that the transporter activities of both GLT-l spiice variants were
maximal when the two transporters are expressed in equal proportion. In addition,
previous studies have reported the existence of both monomer and multimer forms of
GLT-la (Haugeto et al., 1996). Together, these findings suggest that when both
transporters are co-expressed in the same cell membrane, they may interact and form
muhimers, providing a means of quickly modifying transporter activity in which
individual cells can adjust the local efficiency of the transport system. In the present
study, we have also observed multimer bands for both GLT-la and GLT-lv. Such
findings support this concept of an interaction between both transporters. further
studies will be required to examine the precise nature of the functional relationship
between these two variants of GLT- 1.
In the present study, GLT- 1v irnmunoreactivity appears to be predorninantly
localized to astrocytes, consistent with earlier findings (Reye et al., 2002). In addition,
GLT- 1v downregulation is transient in the hippocampus and the thalamus, making it
more likely that the antibody is targeting prirnarily astrocytes rather than neurons, the
latter of which die under these conditions. On the other hand, Schrnitt and colleagues
(2002) have reported that a similar spiice variant of GLI- 1 appears to be concentrated
in neurons. We have not been able to confirm these findings with GLT-lv in the three
brain regions examined in the present study. Nevertheless, such reports along with
ours suggest the existence of different forms of GLT- 1, perhaps with celi type- and
region-specific roles to play in terms of glutamate clearance.
The fact that GLT-lv is expressed in astrocytes near glutamatergic synapses,
and that this splice variant might form heterornultirners with GLT-la to regulate the
uptake of glutamate transport activity together suggest an important contribution of
this splice variant to the development of excitotoxicity in this model. Our resuits
showed no change in the levels of EAAC 1 in any of the 3 regions examined in this
study. EAAC1 is reported to be absent in glutamatergic nerve terminals (Danbolt et al.,
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1998), and antisense knockdown of EAAC 1 did not exacerbate the degree of neuronal
damage arising from transient focal cerebral ischemia (Rao et al., 2001a). Such
flndings lead us to conclude that this transporter does not participate to any great
extent in the neuronal damage arising from this type of fluid-percussion injury. Our
observations of a loss in GLT-lv suggest an important role for this transporter splice
variant in TBI. Additional studies focussing on the controlling rnechanisms
rcsponsible for this effect should yield further insight into the exact role of GLT- lv,
along with potential therapeutic strategies for improved treatment of the resulting
neuronal damage.
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Table 1. Regional neuronal ceil counts
Cerebrai Hippocampus Thalamus
cortex (CA2) (PTN)
$ham(n=5) 130±4 75±2 80±4
6 hr post-TBI (n = 6) 68 ± lia 45 ± 3’ 47 ± 5a
24 hr post-TBI (n = 6) 30 ± 27 ± 6a,b 27 ±
Values are mean ± SEM. significantly different compared to sham (p < 0.001),
b significantly different cornpared to 6 1w post-TBI group (p <0.05); ANOVA
with post-hoc Bonferroni correction. PTN, posterior thalarnic nuclei.
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Figure 1
Regions of interest in the rat brain following lateral fluid-percussion injury.
Levels 1-3 are representative of coronal sections ranging from -4.16 to -5.8 mm
relative to bregma according to the rat brain atlas of Paxinos and Watson (199$).
Shaded areas show the underlying injured frontal parietal cortex (A), hippocampus (B)
and posterior dorsal lateral thalamus (C) utilized in immunoblotting studies.
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Figure 2.
Effect of fluid-percussion injury on the levels of four glutamate transporters in
the injured cerebral cortex following 131. A) Immunoblots show representative bands
for GLT-la, GLT-lv, GLASI, EAAC1 and actin. B) Quantitative densitometric
analysis of shams (n = 5), and 6 hr (n = 6) and 24 hr (n = 6) following injury. Levels
of GLT-lv are decreased as early as 6 hrs with further down-regulation at 24 hr post
injury. Samples ofthe injured cortex were dissected out and processed as described in
the “Materials and Methods” section. Lanes were loaded with equal amounts of
protein in each case (GLT-la, 10 tg; GLT-lv and EAAC1, 50 tg; GLAST, 35 tg;
actin, 20 tg). *p <0.05 compared with sham levels (ANOVA with post-hoc Duirn’s
test).
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Figure 3.
Effect of fluid-percussion injury on GLT-l spiice variant levels in the
ipsilateral hippocampus and thalamus following TBI. A) Immunoblots show
representative bands for GLT- Ï Œ, GLT- lv and actin. B) Quantitative densitornetric
analysis of shams (n 5), and 6 hr (n = 6) and 24 hr (n = 6) following injury. Levels
of GLT-lv were transiently decreased in both brain regions at 6 hi post-injury,
whereas GLT- la showed an up-regulation in hippocampus, but no change in thalamus.
*p <0.05 compared with sham levels (ANOVA withpost-hoc Dunn’s test).
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Figure 4.
Regional changes in GLT- lv immunoreactivity following fluid-percussion
injury. Photomicrographs of coronal sections from sham (n = 4), 6 hr post-TBI (n = 4),
and 24 hr post-TBI animais (n = 4). Cresyl violet staining of the injured cortex (Cx)
shows progressive neuronal loss at 6 and 24 hr following trauma cornpared to sham
(A-C). This is accompanied by a decrease in GLT-lv irnrnunoreactivity at 6 hr (E,
arrows) with further loss at 24 hi (F, anows). In the hippocampus (Hc) and thalamus
(Th), GLT- 1 y immunoreactivity is transiently decreased at 6 hr (H, K) cornpared to
sham (G, J) (airows), but recovers to sham levels at 24 hi (I, L). Bar represents 200
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Figure 5.
Differential changes in GLT-la and GLT-lv immunoreactivity in the
hippocampus. Photomicrographs show coronal sections from representative sham (n =
4), 6 hr post-TBI (n = 4), and 24 hr post-TBI animais (n 4). GLT-lv is transiently
lost at 6 hr, returning to sham levels at 24 hrs (A-C), whereas GLT-IŒ
immunoreactivity is increased in the ipsilateral hippocampus (D-f). Note staining of
astrocyte processes for GLT-lv (A) and considerable loss of GLT-Ïv
inrniunoreactivity in stratum radiatum tSR) at 6 hr post-trauma (B). ConsiderabÏe
neuronal damage is apparent in the CA2 hippocampal subfield, with more intense
GLI- 1 Œ immunoreactivity in astrocytic processes around pyramidal celis compared to
sham (G-I). 5G, stratum granulosum; SP, stratum pyramidale. Bars represent $0 tm in
A-F, and 40 tm in G-I.
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Figure 6.
Pattern of GLI- 1v, glutamine synthetase (GS), and guai fibrillary acidic
protein (GFAP) immunoreactivities in the cerebral cortex and hippocampus of a
representative sham animal (n = 4). Comparison of the immunostaining profiles for
GLT-lv (A-D) and the two astrocyte-specific proteins GfAP (E-H) and G$ (I-L)
show a close similarity in which the processes of astrocytes are well defined, with an
absence of neuronal staining in cerebral cortex, and stratum pyramidale (SP) and
stratum moleculare (SM) of hippocampus. D, H, and L are from the SM layer of
panels C, G, and K respectively. Bar represents 100 tm in A, C, E, G. I, and K, and 25
tm in B, D, f, H, J, and L.
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Figure 7.
Relationship between GLT-lv and neuronal damage in the injured cerebral
cortex following lateral fluid-percussion injury. A) Correlation between GLT-lv and
neuronal ceil counts. A significant positive correlation (p = 0.000 1) was found
between GLT-lv (normalized to actin) and celi numbers. The regression une shown is
y = 0.003x + 0.02 in which the Pearson’s product-rnoment correlation coefficient, r =
0.78. Data are from ail animais in the three groups (n = 17). 3) Quantitative
immunoblot analysis of the neurofilarnent protein Œ-internexin. Representative
immunoblot showing Œ-intemexin bands at 6 and 24 1w post-TBI cornpared to a sham
control. Densitornetric analysis reveals decreased levels of Œ-intemexin at 24 1w post
injury. Lanes were loaded with equal amounts of protein in each case (20 1g). Arrow
shows position and size of the migrated protein. *p < 0.05 compared to sham level
(ANOVA with post-hoc Dunn’s test). C) Correlation between GLT-lv and u
internexin. A significant positive correlation (p = 0.035$) was found between GLT-lv
and u-internexin. The regression une shown is y = 0.49x - 0.11 in which the Pearson’s
product-mornent correlation coefficient, r = 0.51. Data are from ail animais in the
three groups (n = 17).
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Figure 8.
Graphical display summarizing the regional changes in expression levels of
GLT-la, and GLT-lv at 6 hr and 24 hr following fluid percussion injury. Decrease in
GLT-lv, but flot GLT-la, is positively correlated with neuronal loss. Abbreviations:
IC, injured cortex: Hc, hippocampus; Th, thalamus.
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2.2 Article 2
Early, transient increase of complexin I and II in the cerebral cortex following
traumatic brain injury is attenuated by N-acetylcysteine.
Journal of Neurotrauma 23(1), 86-96 (2006)
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ABSTRACT
Alteration of excitatory neurotransmission is a key feature of traumatic brain
injury (lEI) in which extracellular glutamate levels rise. Although increased synaptic
release of glutamate occurs at the injury site, the precise mechanisrn is unclear.
Complexin I and complexin II constitute a family of cytosolic proteins invotved in the
regulation of neurotransmitter release, competing with the chaperone protein Œ-SNAP
(soluble N-ethylmaleirnide-sensitive factor-attachment protein) for binding to the
synaptic vesicle protein synaptobrevin as well as the synaptic membrane proteins
SNAP-25 and syntaxin which together form the SNAP receptor (SNARE) complex.
Complexin I is predominantly a marker of axosomatic (inhibitory) synapses, whereas
complexin II mainly labels axodendritic and axospinous synapses, the rnajority of
which are excitatory. In order to examine the role of these proteins in IBI, we have
studied levels of both complexins in the injured hemisphere by immunoblotting
following lateral fluid-percussion brain in] ury in the rat. Transient increases in the
levels of complexin I and complexin II proteins were detected in the injured cerebral
cortex 6 h following lEI. Ihese effects were completely blocked by N-acetylcysteine
(NAC) administered 5 minutes following trauma, suggesting an involvement of
oxidative stress. Neuronal loss was also reduced in the injured hemisphere with post
TBI NAC treatment. Our findings suggest a dysregulation of both inhibitory and
excitatory neurotransmission following traumatic injury that is responsive to
antioxidant treatment. These alterations in complexin levels may also play an
important role in neuronal celi loss following TBI, and thus contribute to the
pathophysiology of cerebral damage following brain injury.
Running titie: Complexins in TBI
Key words: traumatic brain injury, neurotransmitter, excitotoxicity, complexin, fluid
percussion, antioxidant
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INTRODUCTION
Traumatic brain injury (TBI) is a rnultifaceted disease. Complications such as
intracranial hernorrliages and diffuse axonal injury can occur that could contribute to
or superimpose upon secondary damage such as isciemia, oxidative stress, and
massive edema. $uch secondary injury can cause profound alterations of endogenous
neurochemical processes including excitatory mechanisms that may be a major cause
of neuropathological damage.
Glutamate is the major excitatory neurotransmitter in brain. In both humans
and animal models of T3I, an abrupt increase in extracellular levels has been well
documented (Faden et al., 1929; Katayama et al., 1990; Palmer et al.. 1993; Bullock et
al., 1998). Such a rise in interstitial glutamate lias probably many origins;
extravasation of blood into the parenchymal space (Koizumi et al., 1997),
development of membrane micropores leading to release of structural amino acids
(Bullock et al., 1998), glutamate uptake dysfunction due to downregulation of the
astrocytic glutamate transporters GLT-1 and GLAST (Rao et al., 1998; Yi et al., 2004),
and enhanced synaptic release and subsequent overflow from the synaptic terminal.
Increased glutamate levels can play a major role in the development of secondary
excitotoxic injury; thus understanding the exact source of post-traumatic glutamate
increase is necessary in order to improve our understanding and develop potential
therapeutic strategies.
Complexins are 15-16 kDa cytosolic proteins that compete with the chaperone
protein a-SNAP (soluble N-ethylmaleirnide-sensitive factor-aftachment protein) for
binding to SNAP receptors (SNAREs) at the presynaptic terminal (Pabst et al., 2000).
These SNAREs consist of the synaptic vesicle protein synaptobrevin as well as the
synaptic membrane proteins SNAP-25 and syntaxin 1 (McMahon et al., 1995; Pabst et
aI., 2000). Complexins have been shown to rapidly bind to the SNARE complex in an
anti-parallel configuration and with high affinity (Pabst et al., 2002). However, the
exact contribution of complexins to neurotransmitter release lias been a controversial
issue, with some studies indicating that complexins play a negative role in exocytosis,
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and others suggesting a positive role in neurotransmiffer release (Ono et al., 1998;
Reim et al., 2001).
Notably, the localization of complexin I in inhibitory neurons and complexin II
in excitatory neurons in the cerebellum and hippocampus (Takahashi et al., 1995;
Ishizuka et al., 1999; Yamada et al., 1999) has perrnitted differential assessment of
excitatory and inhibitory pathways (Eastwood et al., 2001). In psychological disorders
such as major depression, bipolar disease and schizophrenia (Sawada et al., 2002;
Eastwood and Harrison, 2001). complexin levels have been measured in post-mortem
brain tissue in order to assess the extent of excitatory or inhibitory involvernent in the
region of interest. Moreover, in a transgenic mouse model of Huntington’s disease,
progressive loss in complexin II was detected (Morton and Edwardson, 2001),
indicating the potential importance of this novel presynaptic protein in
neurodegenerative disease states.
In brain trauma, the mechanisms by which increased brain glutamate and
GABA levels occur following injury remain unclear. In this study, we have rneasured
changes in complexin levels in brain regions of rat subjected to lateral fluid-percussion
(FP) brain injury of moderate severity in order to determine whether TBI might alter
excitatory and/or inhibitory neurotransmission via an effect on this part of the synaptic
release rnachinery. In addition, we exarnined whether changes in complexin levels
may be due to oxidative stress-related events, via treatment of animals with the well
known antioxidant N-acetylcysteine (NAC). Our resuits demonstrate, for the first time,
that TBI resuits in a dynamic change in complexin I and complexin II protein levels,
and that this change is likely associated with oxidative stress.
MATERIALS AND METHODS
Materials
Protease inhibitor cocktail, mouse monoclonal antiserum to -actin, rabbit anti
goat IgG secondary antibody, 3,3’-diaminobenzidine (DAB), nickel ammonium
sulfate and sodium azide were purchased from Sigma Chemicals Co (St. Louis, MO,
USA). Agarose-rabbitt IgG was purchased from Sigma Aldrich (Canada).
$3
Polyvinylidene difluoride (PVDf) membranes were purchased from Bio-Rad
Laboratories (Hercules, CA, USA), broad-range protein markers were purchased from
Arnersharn Canada Ltd (Oakville. ON, Canada), enhanced chemiluminescence kits
were purchased from Perkin Elmer (Woodbridge, ON Canada), and X-OMAT
autoradiography film was purchased from Kodak (11e de Soeurs, Quebec, Canada).
Complexin I and II antibodies were generous gifi from Dr. Ken Sawada (Vancouver
general hospital, Canada) and Seiichi Takahashi (Koichi medical school, Japan) and
previously characterized (Takahashi et al., 1995). Biotinylated donkey anti-rabbit,
anti-goat and anti-mouse antibodies were purchased from Santa Cruz Biotechnology,
Inc (Santa Cruz, CA, USA). Protein A/g-agarose conjugate was purchased from Santa
Cruz Biotechnology (Santa Cruz. CA, USA)..Monoclonal anti-nitrotyrosine antibody
was purchased from Upstate Biotechnologies (USA).
Brain injury mode!
Ail procedures were undertaken with the approval of the Animal Ethics
cornrnittee of Hôpital Saint-Lue and the University of Montreal, and were conducted
in accordance with the guidelines set out by the Canadian Council on Animal Care. A
total of 66 male, Sprague-Dawley rats (350-400g, Charles River, QC, Canada) were
housed under constant conditions of temperature, humidity, and 12:12 h day/night
cycle. The lateral (parasagittal) model of traumatic brain injury used in this study has
previously been described in detail (Mclntosh et al., 19$9). A 4.$mm diarneter
craniectomy, centered between bregma and lambda, and 2.Smrn lateral to the superior
sagittaL sinus was made over the lefi hernisphere using a trephine drill, and a hollow
fernale Luer-Lok fitting secured with dental cernent. One group of rats was
subsequently allowed to recover overnight and, the following day, reanesthetized with
2% isofluorane and subjected to lateral fP injury of moderate severity (2.0-2.5 atm, n
= 52). Sham-injured controls (n = 14) received identical treatment but without
exposure to trauma. Animais were allowed to recover for 6 h, 24 h, 72 h (3 days) and
16$ h (7 days) post-injury prior to sacrifice. For the administration ofNAC, rats were
administered either antioxidant (163 mg/kg, i.p., n = 21) or an equivaient volume of
saline (n = 21) 5 min following TBI. Previous study in our group showed reduced
$4
injury volume and Herne oxygenase-I induction at this arnount ofNAC administration
(Yi and Hazeil, 2005).
Inunuitobtotting
Animais were anesthetized with pentobarbitai (60 mg/kg, i.p.) and the brains
were rernoved and rapidly frozen in isopentane on dry ice, sectioned into appropriate
regions corresponding to the injured cerebrai cortex, hippocampus and thalamus as
previously described (Yi et al., 2004). Tissues were homogenized in ice cold TE
buffer (50 mM Tris, 150 mM NaC1) with a protease inhibitor cocktail (Sigma
Chernical Co., St. Louis, MO, USA) and phenylmethylsulfonyl fluoride using a Teflon
glass homogenizer at 1000 rpm, 25 strokes, on ice. The resuiting homogenate was
centrifuged for 30 minutes at 15 000 x g, 4 °C, and the supernatant was separated into
another tube. Protein content was determined using Bio-Rad DC Protein Assay kit
(Hercules, CA, USA). Immunoblotting assays were perforrned as previously described
(Yi et al., 2004). Briefly, 10 to 15 micrograms of tissue were boiled in equal volume
of 2X Laemmli buffer with 0.1 M dithiothreitol (final concentration) for 5 mm, and
separated using discontinous sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) consisting of 13% resolving and 4% stacking gels,
separated overnight at 40 V, and then transferred to PVDF membranes at 20 V
constant voltage overnight at 4°C. These membranes were subsequently probed for
complexin I (1:1,000) and complexin 11(1:1,000) using hybridoma-derived antibodies
or for 3-actin (1:20,000) using a monoclonal antibody (Sigma Chemical Co., St. Louis,
MO, USA), and semi-quantitation of the intensity of immunobands was performed
using a microcomputer-based image display system (Imaging Research Inc., St.
Catherines, ON, Canada).
Imnutnoprecipitation
four hundred micrograms of the homogenates from normal rat tissue prepared
as described in the immunoblotting section were used for immunoprecipitation
experiments. The samples were precleared with control IgG (agarose-rabbit IgG,
Sigma-Aidrich, Canada) together with 20 ii of appropriate suspended (25% v/v)
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agarose conjugate (protein A/g-agarose, Santa Cruz, USA) for 1 h at 4 oc with
agitation. Afler brief centrifugation (1 000 x g, 30 sec, 4 °C), supernatants were
transferred to new microtubes and incubated with complexin primary antibody (1:100)
for 1 h at 4 °C with agitations. The prirnary antibody was omitted for negative control
(-Ab). At the end of incubation, 20il of appropriate agarose conjugate suspension was
added and the tubes lefi at 4°C overnight on a rocker platform with gentie shaking.
The next day, tubes were centrifuged and supematants were discarded. Resulting
pellets were resuspended in 20pi of TE buffer following washes (4 tirnes) with lx
phosphate buffered saline. Ten t1 was loaded onto SDS-PAGE gel, and ran under
non-reducing condition (no DTT, no boiling) for figure 1. Rainbow wide-range
molecular weight rnarker used to determine the approxirnate molecular weight of
complexins was purchased from Amersharn, USA.
Inmiunohistochernistry and Histology
for immunostaining and histology, rats were deeply anesthetized with
pentobarbital (60 rng/kg) and perftised transcardially as described previously (Hazeil
et aI., 2001). Briefly, brains were rernoved and post-fixed overnight in neutral
buffered formalin containing 4% formaldehyde, 0.5% sodium phosphate buffer, and
1.5% methanol, pH.7.O. Coronal sections (-3.8 to -5.8 min relative to bregma) were
cut (5 jim thickness) from paraffin-embedded blocks of tissue or with a vibrotome (40
irn thickness). Paraffin-embedded sections were stained with cresyl violet.
Vibrotome-cut sections were processed as previously described (Yi et al., 2004) for
complexin I and complexin II immunohistochemistry. Anti-nitrotyrosine
irnmunohistochernstry was performed according to the manufacturer’s recomrnended
procedure. Following washing and alcohol dehydrations, the resulting sections were
mounted on Superfrost Plus siides (Fisher Scientific, Ottawa, ON, Canada), cleared in
xylene (Fisher Scientific, Ottawa, ON, Canada), and coverslipped with Permount
(f isher Scientific, Ottawa, ON, Canada). Neuronal ceil numbers were assessed by
counting and averaging of four adjacent grid areas (0.06 mm2 each) at a magnification
of400X using an Olympus BX-51 light microscope.
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Statisticat analysis
Statistical analysis for the quantitative immunoblotting and neuronal counting
was performed using analysis of variance (ANOVA) with post-hoc Tukey test (p <
0.05) and the Mann-Whitney Utest (p<O.05).
RESULTS
FP brain injury of moderate severity caused an acute and transient increase in
complexin I and II protein levels in the ipsilateral (injured) temporal-parietal cortex,
detected by immunoblotting. Immunoblots showed a single distinct band (Fig. 1 A) on
13 % SDS-PAGE gels for complexin I (15 kDa) and complexin 11(16 kDa) under
reducing condition, as previously reported (Yamada et al., 1999). For complexin I,
what appears to be a dimer band also was detected when the homogenates were ran
under non-reducing condition (Fig. lB), but addition of DTT and boiling the samples
before ruirning the gel completely abolished forming of this dimer hand for complexin
I, resulting in appearance of single hand. Immunoprecipitation and subscquent
immunobotting dernonstrated that the antibodies are specific to each complexin and do
not cross-react between the two complexins (Fig. lB). The transient increase was
particularly evident in the case of complexin I, where the protein level increased
approximately 150 % of sham level at 6 h post injury (Fig. 2A). Levels of complexin
II showed a sirnilar transient increase, but which was less pronounced, showing 50 %
increase at 6h post-TBÏ (Fig. 2A). This increase was only seen in the injured cortex,
and not other regions studied such as hippocampus (Fig. 2B) and thalamus (Fig. 2C).
Interestingly, a srnall but significant decrease of complexin I level was detected at 3
and 7 days following trauma in the injured cortex (42 % at day 3, 44 % at day 7) and 7
days following trauma in hippocampus (31 % at day 7), suggesting diminished
inhibitory input at these tirne points in the regions (Fig. 2A, B). In the injured
thalamus, both complexin I (40 ¾ at day 3 and 43 % at day 7) and complexin 11(47 ¾
at day 3 and 46 % at day 7) showed a significant decrease from the sham level
following the injury (Fig. 2C). Immunohistochemical studies revealed that numerous
complexin I stained neurons were particularly evident in layers 3-5 of cerebral cortex
$7
(Fig. 3Ai-iii), with several complexin I immunoreactive neurons in the CAl-3
hippocampal subfields (F ig. 3Aiv-vi). In the cerebral cortex, numerous srnall neurons
in layers 5-6 showed intense complexin II immunoreactivity (Fig. 3Avii-ix).
We used nitration of tyrosine residues as a qualitative assessment of arnount of
oxidative damage in the injured cerebral cortex following trauma. Relatively low
number of cells was immunopositive for Anti-NT antibody in the cerebral cortex of
sharn-injured rats (Fig. 33i). Six hours afier the insult, large number of cells showed
positive immunoreactivity for Anti-NT in the adjacent cerebral cortex (Fig. 3Bii), and
NAC treatment partially reduced the arnount of immunopositive ceils (Fig. 3Biii).
When compared using light microscopy, Anti-NT positive neurons shared
morphological similarity with complexin I or Il-immunopositive neurons in the
cerebral cortex (Fig. 3C).
Figure 4 shows the resuits of studies that investigated whether these increases
in complexin levels fotiowing TBI were due to oxidative injury-related events by
treatment with NAC. Histological assessrnent with cresyl violet indicated that the
NAC-treatment produced a 34%, 34%, and 55% reduction in neuronal loss in the
injured cerebral cortex, hippocampus, and thalamus respectively relative to the
contralateral hemisphere 24 h post-TBI when cornpared to the corresponding saline
treated group (Table 1, Fig. 4). In addition, NAC treatment completely abolished the
transient increase in complexin I and complexin II levels observed at 6 h in the injured
cerebral cortex in saline-treated TBI groups (Fig. SA-C). Levels of complexin I in the
injured cortex of NAC-treated rats also displayed a further decrease at 24 h when
compared to levels in the cortex ofnon-NAC-treated IBI animals (Fig. 5A,B).
DISCUSSION
Brain trauma caused a significant increase in the tevels of complexin I and
complexin II in the injured cerebral cortex at 6h post-injury, and this change was an
acute and transient event. At later time points (day 3 and day 7 afier the insuit),
complexin I/complexin II ratio decreased, suggesting reduced inhibitory input in the
injured cortex and also in hippocampus region. In this model of TBI, neuronal loss is
8$
most severe in the cortex; thus, these complexin changes likely reflect an alteration in
synaptic activity that could contribute to the neuronal damage. Our
immunohistochemical findings revealed a differing pattern of compiexin I and
complexin II expression, each being present in different layers of cerebral cortex
which is in une with previous reports (Yamada et al., 1999). As complexin I is
localizcd in axo-sornatic synapses and complexin II in axo-dendritic and axo-spinous
synapses (Takahashi et al., 1995; Ishizuka et al., 1999) that are predominantly
inhibitory and excitatory in naflire, respectively (Peters and Palay, 1996), altered
levels of both complexins likely indicate a dysregulation of both inhibitory and
excitatory neurotransmitter release in the injured cortex.
In the present study, we tested the effect of antioxidant treatment on complexin
levels and on overail neuronal loss following TBI. Use of the well-known antioxidant
NAC has previously been shown to restore the vascular responsiveness to
vasornodulators following midline FP injury in cats (Ellis et al., 1991), to reduce the
decrease in mitochondrial activity following cortical impact injury in rats (Xiong et al.,
1999), and to exert a potent neuroprotective effect in focal cerebral ischemia, also in
rodents (Sekhon et al., 2003). Our findings indicate that NAC treatment completely
reversed the increase in complexin protein levels at 6 h in the injured cortex following
TBI to sham levels. Recently, we reported that NAC administered 5 min post-injury
produced a significant reduction in the volume of injury in rats subjected to lateral fP
(Yi and Hazeil, 2005). In the present study, we have demonstrated that neuronal loss
following TBI was diminished in NAC-treated rats in ail three regions studied. These
results suggest that oxidative stress plays an important role in the histological damage
evident in the cortex, and that alterations in excitatory and inhibitory neurotransmitter
release may be important contributing factors.
Our understanding of the role of complexins lias been limited thus far.
Complexins may either inhibit or promote vesicular release of neurotransmitters, with
conflicting reports of their function. $tudies showing inhibition of vesicular release by
overexpression of complexins in PC12 cells or the injection of complexin antibodies
in squid giant axon indicate that complexins may have an inhibitory effect on
neurotransmittcr release (Itakura et al., 1999; Ono et al., 1998). On the other hand, a
$9
double mutant deletion study has shown a reduction in vesicular release (Reim et al.,
2001), and microinjection of a partial complexin peptide sequence that competes with
the binding of complexin to syntaxin completely inhibited neurotransmitter release at
later fusion steps (Tokumaru et al., 2001), together suggesting that complexins are
positive regulators ofneurotransmitter release.
Regardless of whether complexins may block or enhance neurotransmitter
release prior to or following neurotransmitter vesicle fusion with the plasma
membrane, it seems likeÏy these proteins are a part of the neurotransmitter release
rnachinery. In a recent study, Abderrahmani et al (2004) have shown that both
knocking down or overexpression of complexin I in pancreatic beta-ceils using RNA
interference or overexpression via transfecting vectors expressing the complexin I
gene leads to strong impairment in beta-ceil secretion. Complexins may 5e involved in
rapid closure and recycling of fusioned membranes since overexpression of complexin
II leads to a reduced half-life of synaptic vesicle release events (Archer et al., 2002).
Based on these two findings, complexins may positively regulate synaptic vesicle
fusion. A decrease in complexin availability could resuit in a reduction in the number
of vesicular fusion events, thus lowering the amount of vesicular release. Also,
overexpression of complexins may resuit in rapid closure and recycling of vesicles
leading to premature and incomplete termination of the release event, again limiting
the arnount of vesicular release. In general, it would seem that an adequate level of
these regulatory molecules is necessary for the maintenance of firnctional synaptic
events (Abdenahmani et al., 2004), though the exact function of complexins remains
uncertain.
In summary, our findings of an early transient increase of both complexins
may reflect a change in synaptic activity in the injured cerebral cortex, particularly at
inhibitory synapses, since complexin I levels changed more drarnatically. Oxidative
stress may manifest its effect partly via complexin changes, leading to neuronal loss,
with NAC having an ability to reduce the extent of this effect. At present, the exact
contribution(s) of complexins to synaptic vesicle release and to the arnount of
neurotransmitter released in the injured cortex of rats following TBI remains
undeterrnined. However, very recent expression studies involving complexin I and
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complexin II localization indicate that the functional role of these proteins may be
based flot only on the identity of the neurotransmitter, but also upon the associated
neuronal circuitry (freeman and Morton, 2004). Thus, future studies will be required
to better understand the consequences of changes in complexin levels following TBL
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Table 1. Neuronal counts in the injured cerebral cortex, hippocampus, and thalamus
24 h following TBI in the absence or presence ofNAC treatment.
Saline + TBI NAC + TBI
Ipsilateral Contralateral Ipsilateral Contralateral
CerebralCortex 7±3 61+5 25±5* 55±4
Hippocampus ll±3* 34±2 22±3* 33±1
Thalamus $ ± 1 20 ± 3 17 ± 1 18 + 1
Values are mean ± SEM.p <0.01 compared to contralateral side of sarne group
(ANOVA withpost-hoc Tukey test). tp <0.05 compared to ipsilateral side ofNAC
treated group (ANOVA withpost-hoc Tukey test).
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Figure 1.
Complexin I (Cpx I) and complexin II (Cpx II) are distinct proteins abundantly
present in brain homogenates. (A) Representative western blot bands for Cpx I (white
arrowhead) and Cpx II (black arrowhead) in which forebrain hornogenate (5 tg per
lane) was Ioaded onto $D$-PAGE gel (13%) and electrophoresed under non-reducing
condition, transferred onto PVDF membranes and probed for Cpx I (lefi lane) or Cpx
II (right lane). (B) Immunoprecipitation products (10 pi) for Cpx I (IP-cI) and Cpx II
(IP-cTI) were loaded onto SDS-PAGE gel (13%) and electrophoresed under non
reducing conditions along with immunoprecipitation control (-AB, no antibody),
subsequently transferred, and probed with either Cpx I antibody (left 3 lanes) or Cpx II
antibody (right 3 lanes). Note that complexin antibodies do not cross-react with each
other.
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figure 2.
Complexin I (Cpx I) and complexin II (Cpx II) levels undergo dynarnic
changes following moderate FP injury. Percent optical density (norrnalized to actin
levels) of Cpx I and II in the injured cortex (Ctx) (A). hippocampus (Hc) (B), and
thalamus (Thal) (C) at 5 different time points following trauma. Insets; representative
immunoblots of appropriate region for Cpx I, Cpx II and -actin in sham, 6 h, 24 h, 3
days and 7 days following TBI. Note that in the injured cortex Cpx I levels increased
dramatically at 6h following injury, while Cpx II levels increased to a lesser extent. At
day 3 and 7 in the injured cortex and hippocampus, Cpx I levels decreased but not that
of Cpx II. In the injured thalamus, both complexins showed decreased levels at day 3
and 7 following trauma. Values are converted to percent sham (sham value = 100 %) ±
$.E.M. *p <0.05 compared to sham value (ANOVA with post-hoc Tukey test).
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Figure 3.
(A) Immunohistochemical staining of complexin I (Cpx I) and complexin II
(Cpx II) in the cerebral cortex and hippocampus. In the cortex, numerous Cpx I
immunoreactive neurons were observed (i-iii), with the highest number of neurons
present in layers 2-3 and 4-5. In the hippocampus, several scattered neurons displayed
Cpx I immunoreactivity (iv-vi). Nurnerous srnall Cpx II immunoreactive neurons were
also found scattered in layers 5 and 6 ofthe lateral cortex (vii-ix). Bars, 400 tm (i, iv,
vii); $0 jim (ii, y, viii); 40 tm (iii, vi, ix). (B) Qualitative assessment via
immunohistochemical comparison of nitration of tyrosine residue in proteins using
anti-nitrotyrosine (anti-NT) antibody following sham injury (j), 6 h TBI with saline
injection (ii), and 6 h TBI with N-acetylcysteine (NAC). Injection of NAC reduced
neurons positive for nitrotyrosine staining at 6 h following TBI in the injured cortex.
Bar, 200 1m. (C) Morphological comparison of anti-NT-positive neurons at 6 h
following the injury (j) compared to Cpx I (ii) and Cpx II (iii) in the cortex of sham
rats. Bar, 80 p,m.
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Figure 4.
Cresyl violet staining in animais treated with saline or NAC 24 h following
TBI. NAC treatment reduced neuronal celi loss 24 h following the insuit in injured
cerebral cortex (Ctx) (A-C), hippocampus (Hc) (D-F) and thalamus (Thal) (G-I).
Panels A, D, and G show saline-treated rats 24 h post-TBL Panels B, E, and H show
NAC-treated rats 24 h post-TBI. Panels C, F, and I show the contralateral hemisphere
to the saline-treated rat 24 h following TBI. Bar, 50 im.
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Figure 5.
Effects of the antioxidant NAC on complexin levels in cerebral cortex
following TBI. (A) Representative bands for complexin I (Cpx I), complexin II (Cpx
II), and 13-actin in sharn-treated, 6 h and 24 h post-TBI groups, in the absence or
presence of NAC treatment 5 min following the injury. (B) and (C) Immunoblot
analysis; broken une: NAC-treated, solid une: saline-treated. Transient rise in Cpx I
and Cpx II levels following trauma was blocked by a single injection of NAC (163
rng/kg, i.p.). Values are mean + SEM. *p < 0.05 cornpared to sham-treated group.
(ANOVA withpost-hoc Tukey test). **p <0.05 compared with sanie tirne point ofthe
saline (-NAC)-treated group (Mann-Whitney U test).
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2.3 Artïclc 3
Glutamate transporter EAAT4 is increased in hippocampal astrocytes following
fluïd-percussion injury in the rat.
Submitted to Brain Research
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ABSTRACT
Functional impairment of glutamate transporters contributes to excitotoxic
damage and exacerbation of injury in certain neurodegenerative disorders. Several
high affinity sodium-dependent glutamate transporters have been cloned thus far. 0f
these, EAAT4 is abundantly expressed in Purkinje ceils of the cerebellum in rats.
However, littie is currentty lmown regarding levels of EAAT4 following traumatic
brain injury (131). In this study, EAAT4 changes were examined for up to 7 days
following moderate fluid-percussion by immunoblotting and immunohistochemistry.
TBI caused a 20% and 25 % increase in EAAT4 levels in the injured hippocampus at
day 3 and day 7 following the insuit. Immunohistochernical analysis rcvealed this
increase to be localized in ceils exhibiting morphological characteristics of astrocytes.
In addition, increased EAAT4 immunoreactivity was observed in astrocytes in the
ipsilateral cortex, hippocampus and thalamus at day 3 post-injury, which persisted up
to 7 days following the insuit. Given the reported nove! characteristics of chloride
conductance displayed by this transporter, our findings of increased EAAT4 levels
suggest this protein may play an important role in the pathophysiology of TBI.
Running titie: EAAT4 and brain trauma
Key words: traumatic brain injury, glutamate transporter, excitotoxicity, astrocyte,
fluid-percussion, brain trauma
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INTRODUCTION
Glutamate is the most abundant excitatory neurotransmitter in the brain. It is
not metabolized by extracellular enzymes, but removed from the extracellular space
by reuptake, in which glutamate transporters play a crucial role. The glutamate
transporters GLT-1 and GLA$T have been shown to be key players in glutamate
clearance by gene knockout and knockdown studies (Danboh, 2001; Rothstein et al.,
1996; Tanaka et al., 1997), with localization studies having placed them in the
astrocytic compartment in brain (Lebre et al., 1995). The neuronal glutamate
transporter EAAC-1 has been reported to be less of a contributor to the removal of
extracellular glutamate, owing to its high extrasynaptic localization. However,
information is cmTently lacking regarding additional members of the sodium
dependent high-affinity glutamate transporters in the forebrain region.
Under pathological conditions, e.g. following traurnatic brain injury (TBI) or
ischernic stroke, surges in extracellular glutamate levels can lead to excitotoxic injury
via glutamate receptor overstimulation-mediated mechanisms, if flot regulated tightly
at the synaptic level. Thus, maintenance of glutamate transporter function is crucial
following such insuits to the brain. However, recent findings suggest that glutamate
transport may be impaired at an early stage following trama due to decreased
expression (Rao et al., 199$; van Landergharn et al., 2001; Yi et al., 2005), and
antisense knockdown of GLAST and GLT- 1 have been shown to exacerbate brain
injury following TBI (Rao et al., 2001), supporting this notion.
The glutamate transporter EAAT4 is a member of sodium-dependent high
afflnity family of glutamate transporters that also possesses chloride chaimel
properties and is highly expressed in dendritic spines of Purkinje ceils in the
cerebellum (Delmes et al., 199$). Recently, its expression has been reported in
astrocytes of mouse forebrain and spinal cord (Hu et al., 2003), and in retinal
astrocytes of the rat (Ward et al., 2004). To date, however, little information exists
concerning EAAT4 levels in pathological conditions such as head trauma. In this
study, we have therefore examined EAAT4 protein levels in rat brain following lateral
fluid-percussion injury of moderate severity.
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MATERIALS AND METHODS
Trauma mode!
Ail procedures were undertaken with the approval of the Animal Ethics
Cornmittee of Hopital Saint-Luc and the University of Montreal, and were conducted
in accordance with the guidelines set out by the Canadian Council on Animal Care. A
total of 2$ male, Sprague-Dawiey rats (3 50-400 g) (Charles River, Saint-Constant, QC,
Canada) were housed under constant conditions of temperature, humidity, and 12:12 h
day/night cycle. Rats were prepared for trauma as previousiy described (Yi et al.,
2005). Briefly, animais were anesthetized using sodium pentobarbitai (65 mg/kg, i.p.),
and a 4.8 mm diarneter craniectomy, centered between bregma and lambda, and 2.5
mm laterai to the superior sagittal sinus, was made over the lefi hernisphere using a
trephine drill, and a holiow female Luer-Lok fitting secured with dental cernent. Rats
were fasted overnight prior to this surgical implantation. Animals were subsequently
reanesthetized the following day with 2% isofluorane and exposed to lateral ftuid
percussion injury of moderate severity (2.0-2.5 atm). Sham controis received identicai
treatrnent but without exposure to trauma.
Inununoblotting aitd iminunohistocltemistry
foilowing TBI, animais were sacrificed by decapitation, the brains were
removed and rapidiy frozen in 2-methylbutane on dry ice, appropriate regions
corresponding to the injured cerebral cortex, hippocampus and thalamus dissected out
and homogenized in ice coid Tris-EDTA (TE) buffer with phenylmethylsulfonyl
fluoride (PMSF) and a protein inhibitor cocktail (Sigma Aldrich, Oakville, ON,
Canada) using a Teflon glass homogenizer on ice. Resulting homogenates were
centrifuged for 30 min at 15,000 x g, 4CC. Peilets were washed with TE buffer,
recentrifuged, the supernatant discarded, and the remaining peliet solubiiized in
modified RIPA buffer containing (50 mM Tris, 150 mM NaC1, 2% SDS, 1% NP-40,
0.5% sodium deoxycholate, pH 8.0, with PMSF and protease inhibitor cocktail.
Protein content was determined using a protein assay kit (Bio-Rad Laboratories,
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Mississauga, ON, Canada). Samples were loaded onto 10% SDS polyacrylamide gels,
separated overnight, and transferred to polyvinylidene difluoride membranes at 20 V,
4°C. Membranes were subsequently probed using a rabbit polyclonal antibody
directed against EAAT4 (D537, 0.4 tg/m1; generous gifi from Dr. Niels C Danbolt,
University of Oslo, Norway), and a mouse monoclonal antibody against 13-actin
according to the manufacturer’s recommendations (Sigma Aldrich, Oakville, ON,
Canada). Semi-quantitation of band intensities was performed using a microcomputer
imaging system (MCID, Imaging Research Inc., St Catherines, Ontario, Canada).
For immunohistochemistry, rats were deeply anesthetized with pentobarbital
(60 mg/kg) and perfuse-fixed transcardially as described previously (Hazeli et al.,
2001). Brains were removed and post-fixed overnight in 10% neutral-buffered
formalin (ACP Chemicals, Inc., Montreal, QC, Canada). Coronal sections of 40 tm
thickness (-3.8 to -5.8 mm relative to bregma) were cut using a vibratome based on the
rat brain atlas of Paxinos and Watson (1998). Immunohistochemical assessment of
floating sections was performed according to Hazeli and colleagues (2001). Briefly,
sections were incubated for 10 min in phosphate-buffered saline (PB$) containing
0.3% hydrogen peroxide to block endogenous peroxidase activity. Tissue sections
were then washed in PBS (3 x 10 mm), blocked for 20 min in PBS containing 5%
donkey serurn or 1% bovine serum alburnin, followed by incubation in blocking
solution with rabbit anti-EAAT4 antiserum (D537, 4 tg/m1) for 18 hr at 4°C. The
following day, sections were washed again in PBS (3 x 10 mm) and incubated for one
hour with biotinylated donkey anti-rabbit IgG (1:100) (Santa Cruz Biotechnology, Inc.,
Santa Cruz, CA, USA) in PBS, followed by washing in P35 (3 x 10 mm) and 1 hr
incubation in streptavidin-HRP conjugate (1:100) (Sigma Aldrich, Oakville, ON,
Canada). Sections were then washed in P35 (3 x 10 mm), and then incubated with
3,3’-diarninobenzidine (0.05%) containing 25 mg/ml nickel ammonium sulfate for
signal enhancement in the presence of H2O2 (0.03%) for 2-10 min to allow color
development. Following subsequent washings, the sections were mounted on
Superfrost Plus siides (Fisher Scientific Co., Ottawa, ON, Canada), dehydrated in
serial alcohols, cleared in xylene, and coverslipped with Permount. Controls for
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immunostaining specificity consisted of omission of the primary or secondary
antibody, resulting in a subsequent loss of immunoreactivity.
RESULT$
figure 1 shows EAAT4 protein levels determined from both immunoblotting
and immunohistochemistry. Transporter levels were very high in the cerebellum of
control rats as previously reported (furuta et al., 1997). The 65 kDa EAAT4
immunoblot monorner band for cerebellum was at least 20 times more intense than
that of the hippocampus (Fig. lA). Immunohistochemical assessment also confirmed
this protein expression in the cerebellum, in which Purkinje celis and numerous ceils
of the molecular layer were labeled for EAAT4 (fig. 1 B, panel j), with more scattered
immunostaining in the granule cell layer. In the forebrain region, staining of neuronal
celi bodies and astrocytes was observed tbroughout cerebral cortex, in the
hippocampus and in the thalamus of sham animais (fig. lB, panels ii, iii and iv,
respectively).
Next, we investigated changes in EAAT4 protein leveis in the hippocampus
following TBI. Figure 2A shows representative immunoblots for EAAT4 and 3-actin
in the hippocampus at 3 and 7 days following the insult, cornpared to that of shams.
TBI caused increases in EAAT4 band intensity of 20% and 25% at day 3 and day 7
following the insuit, respectively (p < 0.05) (fig. 2B). Immunohistochemical analysis
revealed that the EAAT4 increase in hippocampus following trauma is predorninantly
localized in astrocytes (Fig. 3). Increased astrocytic EAAT4 staining was also
observed in the injured core region and glia limitans of the cerebral cortex (Fig. 4),
and in the internai capsule and, to a lesser extent, thalamic nuciei (flot shown). These
increases in EAAT4 levels were not detected at earlier time points (6 h and 24 h)
following the insuit in any region.
DISCUSSION
EAAT4 has been cloned in human and rat brain (Fairman et al., 1995; Lin et
al., 1998), and immunohistochemical studies have determined it to be localized
prirnariiy in fleurons, particularly in Purkinje celis and in the mofecular layer of the
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cerebellum (Dehnes et al., 1998; Fairman et al., 1995; Nagao et al., 1997). However,
more recent studies have identified EAAT4 to be also present in astrocytes of
forebrain and spinal cord (Ru et al., 2003). In this study, we confirm that several
astrocytes do indeed express EAAT4 in cerebral cortex, hippocampus and thalamus of
normal rats at relatively low levels, an observation in une with previous findings
(Furuta et al., 1997; Ru et al., 2003). Moreover, EAAT4 levels are increased in
astrocytes, but not neurons, of hippocampus at 3 and 7 days following TBI. To our
knowledge, this is the first study to show an upregulation of astrocytic EAAT4 levels
in the rat forebrain under such conditions.
We previously reported that fluid-percussion injury of moderate severity
caused a loss of the novel glutamate transporter spiice-variant GLT-lv in injured
cerebral cortex (Yi et al., 2005), and this decrease persisted for up to 7 days in cerebral
cortex following the insuit. It is therefore possible that our present findings of an
EAAT4 increase in astrocytes may represent a compensatory response to this loss of
GLT- 1v, with the Km for EAAT4 reported to be approximately 10 times less than
other sodium-dependent glutamate transporters (Fairman et al., 1995), indicating a
higher affinity.
In the present study, EAAT4 immunostaining was also found to be present in
perivascular astrocytes in injured cerebral cortex following TBI, showing a
resemblance to the pattern reported for EAAT4 in the retina (Ward et al., 2004). This
close relationship between EAAT4 and blood vessels suggests a specialized vascular
related function for this transporter, apart from its contribution to clearance of synaptic
glutamate following the injury; a role in blood-brain barrier regulation is one such
possibitity.
EAAT4 displays a high chloride conductance that is not coupled to the
glutamate uptake, a property different to other sodium-dependent glutamate
transporters (fairman et al., 1995). This uncoupled chloride conductance has been
hypothesized to play a role in dampening cellular excitability during the electrogenic
process of glutamate uptake (Wadiche et al., 1995), along with the prevention of a
reduction in the rate of transport that would otherwise occur with electrogenic uptake
(Eliasof et al., 1996), by switching between two modes of ftinction, narnely glutamate
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transport and chloride channel activity (Wadiche et al., 199$). Thus. the EAAT4
increases observed in our study may represent a protective rnechanism for astrocyte
function following TRI. It will be interesting to determine if other chloride channels
such as those associated with GARA-A receptors are altered in fiinction at this stage
following TBI. In addition, ftirther studies on the function of EAAT4 are required to
clarify the exact significance ofthe EAAT4 increases following TBI.
ACKNOWLEDGMENT
This study is supported by a grant from the Canadian Institutes of Health
Research (MOP-53 110), and by the Marie Robert Head Trauma Foundation (Quebec).
REFERENCES
Danbolt NC (2001). Glutamate uptake. Prog. Neurobiol. 65:1-105.
Dehnes Y, Chaudhry FA, Ullensvang K, Lehre KP, Storm-mathisen J, Danbolt NC
(199$). The glutamate transporter EAAT4 in rat cerebeliar Purkinje celis : a
glutamate—gated chloride chairnel concentrated near the synapse in parts of the
dendritic membrane facing astroglia. J. Neurosci. 18:3606-361 9.
Eliasof S, Jahr CE (1996). Retinal guai ccli glutamate transporter is coupled to an
anionic conductance. Proc. Natl. Acad. Sci. 93:4153-4158.
Fairman W. Vandenberg RJ, Arriza JL, Kavanaugh MP, Amara 5G (1995). An
excitatory arnino-acid transporter with properties of a ligand-gated chloride
channel. Nature. 375:599-603.
Furuta A, Martin L Lin CL, Dykes-Hoberg M, Rothstein ID (1997). Cellular and
synaptic localization of the neuronal glutamate transporters excitatory arnino acid
transporter 3 and 4. Neuroscience. 81:1031-1042.
114
Hazeli AS, Rao KV, Danbolt NC, Pow DV, Butterworth RF (2001). Selective down
regulation of the astrocytic glutamate transporters GLT- 1 and GLAST within the
medial thalamus in experimental Wernicke’s encephalopathy. J. Neurochem.
78:560-568.
Hu W, Walters WM, Xia X, Karmally SA, Bethea JR (2003). Neuronal glutamate
transporter EAAT4 is expressed in astrocytes. Qua. 44:13-25.
Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC (1995). Differential
expression of two guai glutamate transporters in the rat brain: quantitative and
immunocytochernical observations. J. Neurosci. 15:1835-1853.
Lin CG, Izingounis AV, Jin L, Furuta A, Kavanaugh MP, Rothstein JD (199$). Brain
Res. Mol. Brain Res. 63:174-179.
Nagao S, Kwak S, Kanazawa I (1997). EAAT4, a glutamate transporter with
properties of a chloride channel, is predominantly localized in Purkinje celi
dendrites, and forms parasagittal cornpartrnents in rat cerebellum. Neurosciecnce.
78:929-933.
Paxinos G, Watson C (199$). The rat brain in stereotaxic coordinates. Academic Press,
San Diego.
Rao VL, Baskaya MK, Dogan A, Rothstein JD, Dempsey RJ (199$). Traurnatic brain
injury down-regulates glial glutamate transporter (GLT-1 and GLAST) proteins
in rat brain. J. Neurochem. 70:2020-2027.
Rao VL, Dogan A, Bowen KK, Todd KG, Dempsey RJ (2001). Antisense knockdown
of the guai glutamate transporter GLI- 1 exacerbates hippocampal neuronal
damage following traumatic brain inj ury to rat brain. Eur. J. Neurosci. 13:119-12$.
115
Rothstein JD, Dykes-Hoberg M. Pardo CA, Bristol LA, Jin L, Kunci RW, Kanai Y,
Hediger MA, Wang Y, Schielke JP, Welty Df (1996). Knockout of glutamate
transporters reveals a major role for astroglial transport in excitotoxicity and
clearance of glutamate. Neuron. 16:675-686.
Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H,
Nishikawa H, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori S.
Takirnoto M, Wada K (1997). Epilepsy and exacerbation of brain injury in mice
lacking the glutamate transporter GLT- 1. Science. 276:1699-1702.
van Landerghem FK, Stover If, Bechmann I, Bruck W, Unterberg A, Buhrer C, Von
Diemling A (2001). Early expression of glutamate transporter proteins in ramified
microglia afier controlled cortical impact inj ury in the rat. Glia. 35:167-179.
Wadiche II, Kavanaugh MP (199$). Macroscopic and microscopic properties of a
cloned glutamate transporter/chloride channel. J. Neurosci. 18:7650-7661.
Wadiche II, Amara SG, Kavanaugh MP (1995). Ion fluxes asoociated with excitatory
arnino acid transport. Neuron. 15:721-72$.
Ward MM, Jobling AI, Puthussery T, foster LE, Fletcher EL (2004). Localization and
expression of the glutamate transporter, excitatory amino acid transporter 4,
within astrocytes of the rat retina. Celi. Tissue. Res. 315:305-3 10.
Yi J, Pow DV, Hazeil AS (2005). Early loss ofthe glutamate transporter spiice-variant
GLT-lv in rat cerebral cortex following lateral fluid-percussion injury. Glia.
49:121-133.
116
Fïgure 1.
Comparison of EAAT4 protein expression in rat cerebellum and forebrain
regions. (A) Representative immunoblot bands for EAAT4 in cerebellar tissue (cbm, 5
tg loaded) and hipppocarnpus tissue (Hc, 50 jig loaded), analyzed by 10 % SD$
PAGE. (B) Immunohistochemical analysis of EAAT4 expression in cerebellum (i),
cerebral cortex (ii), hippocamus (iii) and thalamus (iv). Arrow in B (j) points to
cerebellar Purkinje ceils darkly stained for EAAT4. Both neuronal (white arrowheads)
and astrocytic (black anowheads) staining was observed in cerebral cortex,
hippocampus, and thalamus. ml; molecular layer. gl; granule celi layer. Bar; 50 rn.
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Figure 2.
Hippocampal EAAT4 is increased at days 3 and 7 following TBI. (A)
Representative immunoblot bands for EAAT4 in the injured hippocampus following
sham-injury (S), 3 days (d3) and 7 days (d7) following moderate fluid-percussion
injury in rats. fifty micrograms of tissue were loaded onto 10 % acrylamide gel,
transferred overnight and probed with anti-EAAT4 polyclonal antibody. (B) EAAT4
immunoblot band intensity norrnalized to actin showed a rnodest but significant 20
% and 25 % increase at day 3 and 7 following trauma, respectively, relative to sham
level (asterisks, Tukey test, p<O.O5).
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Figure 3.
EAAT4 immunohistochemistry showing increased astrocytic staining
throughout hippocampal region at day 3 (B, E) and 7 (C, F) following TBI compared
to sham (A, D). Bar; 200 jirn for A, B, and C, and 50 j.irn for D, E, and F.
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Figure 4.
EAAT4 immunohistochemistry in cerebral cortex following sham (A), day 3
(B) or day 7 afier TBI (C, D). Many astrocytes were stained positive for EAAT4 afier
the injury especially near the traurnatic core (B. C) and guai lirnitans (D). Note peri
vascular localization of EAAT4 immunopositive ceils. Bar; 50 jim.
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CHAPTER 3
DISCUSSION
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3. General Discussion
This section aims to examine the relevance and significance of resuits obtained
from the studies undertaken. Some unpublished data will also be discussed and, in
conjunction with the data presented in the articles, will be used to draw a general
conclusion of the thesis.
3.1 Contribution of glutamate transporter changes following TBI
3.1.1 Discussion on key points of Article 1: Early loss of protein expression of
GLT-lv in the injured cerebral cortex following FPI
b determine the potential role of high-affinity sodium-dependent glutamate
transporters in the early pathophysiology of experirnental trauma, semi-quantitation of
immunoblot bands and immunohistochemical staining of these proteins were
employed to study the rat brains following acute FPI (6 and 24 hrs) or sham injury
utilizing polyclonal antibodies specific for each transporter protein. From such
experiments, the following results were obtained; 1. Glutamate transporter GLT- 1 x,
GLAST, and EAAC1 showed no change following insult in the injured cerebral cortex,
2. Level of GLT-lv, the C-terminal spiice variant of GLT-1Œ, decreased progressively
in the injured cerebral cortex, 3. Injured hippocampus showed an increased relative
imrnmunoreactivity of GLT-1Œ, but flot GLAST and EAAC1, 4. Injured thalamus
showed no change in the relative immunoreactivity for GLT- 1 Œ, GLAST, and EAAC 1,
5. Both injured hippocampus and thalamus showed transient decrease in the relative
irnmunoreactivity in GLT- 1v at 6h following inj ury. These alterations in the protein
levels of glutamate transporters were brain region specific, and suggest a differential
but unique contribution of the transporters in these three regions of the brain in the
development of neurodegeneration following FPI. As loss in the protein content of
glutamate transporters influences the glutamate clearance capacity of that region, an
increase in extracellular glutamate concentration is possible, hence resulting in a
potential for secondary excitotoxic injury via neurotoxic action of glutamate. In
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addition, the current finding showing the loss of GLT- lv, a C-terminal spiice variant
of major astrocytic brain glutamate transporter GLT-1Œ, represents a unique
opportunity whereby the functional role of two splice variants can be studied
separately from each other.
3.1.1.1 Mechanism(s) involved in Ioss of GLT-lv protein following FPI
Although the decrease in the GLT-lv protein level was flot followed up by an
investigation of change in the messenger RNA level following trauma, it is apparent
that the loss of GLT-lv protein is not likely due to a loss in the messenger RNA as the
protein turnover rate (degradation-de novo synthesis) of glutamate transporter GLT-1
protein is typically at least 48 hrs (Zeleania and Robinson, 2000) and the earÏiest time
that loss of GLT-l transporter protein lias been detected is 2 hrs following trauma
(Rao et al., 1998). Tt is thus likely that a selective degradation via proteolysis (or other
undeflned active processes) accounts for this downregulation that occurs afier trauma.
According to Beckstrom et al (1999), the C-terminal amino acid sequences of
GLT-la are more vulnerable to protein degradation-related loss of immunoreactivity,
and the loss of immunoreactivity does not necessarily correlate to loss of [3H]D-
aspartate ‘binding’ nor the glutamate uptake activity from reconstituted liposomal
preparations. In this respect, the selective loss of GLT-lv reported in the present study
is interesting at many levels. first, the loss of GLT-lv, and not GLT-1Œ, questions
whether this loss is due to ubiquitous degradation of c-termini of glutamate
transporters following fPI. Rather, it seems that some other mechanism(s) that leads
to a selective splice variant specific degradation is acting.
In primary cultures of non-differentiated astrocytes, the PKC-dependent
phosphorylation mechanism could resuit in the loss of irnmunoreactivity of GLA$T,
but not the decrease of protein and ftinction itself, suggesting a regulatory mechanisrn
of GLAST whereby an apparent uncoupling of transporter immuno-content versus
transport activity occurs ($usarla et al., 2004). If PKC-dependent phosphorylation is
considered, it is important to keep in mmd that the consensus PKC-phosphorylation
sites are conserved between GLT-lv and GLT-la splice variants, unless there are
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unidentified phosphorylation site(s) within the 12 amino acids unique to GLT-lv.
Since it shares high hornology with GLT-1Œ, the selective downregulation will not
occur if the mechanism of loss of irnmunoreactivity (downregulation) is due to PKC
dependent phosphorylation on the consensus phosphorylation sites alone. However, in
their study, $usarla et al (2004) suggests the downregulation of GLAST to be due
possibly to phosphorylation on the GLAST protein sites that are flot consensus PKC
phosphorylation sites, as GLAST is known to be phosphorylated in other regions as
well (Conradt and Stoffel, 1997). So far, the phosphorylation-dependent (and activity
independent) loss of irnmunoreactivity like that of GLA$T (Susarla et al., 2004) has
not yet been reported for GLT- 1. In addition, since there was no detectable change in
the GLA$T level following trauma, it is unlikely that such a phenomenon is at play in
the traumatized brain, but rather is likely to be confined to in vitro celi culture setting
(primary astrocytic culture).
3.1.1.2. Potential contribution of the loss of GLT-lv protein in the
pathophysiology of trauma
The relatively narrow appearance of GLT-lv band on the gel is suggestive of a
low amount of this protein present in the given region. No significant downregulation
of GLT- 1 was observed following FPI when an N-terminal specific antibody was
employed (unpublished observation), nor GLT- 1 a using a specific C-terminal
antibody (this article, Figure 2). If the immunocontent of GLT-lv were to be of
significance in the whole GLT immunocontent, one might expect that a decrease of
80% in relative immunoblot intensity of GLT-lv seen in the cerebral cortex 24 hr after
FPI should have been detected, albeit relatively less pronounced, when N-terminal
pan-GLT antibody was employed. The lack of this detection suggests considerably
lower amount of GLT- 1v present in the cerebral cortex in relation to GLT- 1 a. In
support of this view, a significantly high amount of protein samples are loaded on the
gel for immunoblotting of GLT-lv (50 cg/well), whereas only one fifih of that arnount
was used for GLT-la, and yet the difference in the immunoblot hand intensity
between the two splice variants was quite huge, with GLT- 1 a band intensity much
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more pronounced compared to that of GLT- 1v. This view is in conflict with Chen et al
(2002) whereby the protein level of GLT-la and that GLT-lv were shown to be
comparable in many regions of the brain, as well as in primary astrocytes afier
dibutyryl cyclic AMP treatment by western blot. However, in the successive
publication, Chen et al (2004) showed concern regarding the authenticity of their
paper in 2002 for the specificity of GLT-1Œ and GLT-lv antibodies, and further
showed that the messenger RNA distribution of GLT- 1 Œ to be the predominant
isoform expressed in the brain (Berger et al., 2005). Despite these findings, the
contribution of GLT-lv in removal of interstitial glutamate in respect to its
localization and relative expression level in different regions of brain remains to be
elucidated.
The formation of multimer hands for GLT-lv suggests that this protein has the
characteristics of a glutamate transporter (Haugeto et al., 1996). When brain sections
were examined by irnmunohistochemistry, the GLT-lv antibody revealed astrocytic
labeling pattern in the cerebral cortex and hippocampus approximating, yet unique
from that of GLT- 1 a, but also further away from synapses, staining astrocytic somata
rather than processes, in une with previous publications (Reye et al., 2002; Sullivan et
al., 2004). Although resuits from the testing of antibody via immunochemical
procedures are in line with glial GLT-1 in the literature, the unequivocal test to show
the authenticity of antibody binding will require the use of a knockout. The polyclonal
antibodies to GLT- 1v and GLT- 1 Œ (not affinity purified, but supplied in crude serum)
that were employed in our study were provided by Dr. David V Pow, but there have
been no knockout studies to verify the authenticity of labeling. It is questionable that
generation of selective GLT- 1 v-null mice can be established; however, for the purpose
of validating antibody specificity, one might consider testing the authenticity of
antibody on preexisting GLT-1 null mice (Tanaka et al., 1997) in the future since both
GLT variants will be knocked out.
As indicated in the Discussion section of the first article, it is likely that the
unique C-terminal PDZ-binding sequence provides a due to the exact role of the GLT
1v spiice variant in the brain. The recent finding that the PDZ sequences in the GLT
1v interact with PICK-1 (Chen and Rosenberg, 2002), and that there may be an
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interaction of PICK- 1 and the glutamate metabotropic receptors, suggest an interesting
avenue of research for future studies.
3.2. Contribution of complexin I and II changes following TBI
3.2.1 Discussion on key points of Article 2: Early, transient increase of complexin
I and II in the cerebral cortex following traumatic brain injury is
attenuated by N-acetylcysteine
If the main function of complexins I and II in $NARE-mediated synaptic
exocytosis is the stabilization of SNARE complexes in a tight conformation thus
maintaining a highly Ca2 sensitive pool ofready releasable vesicles (Reim et al., 2001;
Chen et al., 2002), then the transient increase in the complexins level in the injured
cerebral cortex following FPI would favor the likelihood of increased exocytosis and
subsequent rise in extracellular glutamate concentration.
Interestingly, the acute, transient increase of complexin I and II protein level
after injury (Article 2, Figure 2) is independent of messenger RNA levels, when RT
PCR was perfornied (unpublished findings). At 6 and 24 hr following injury,
complexin I messenger RNA levels showed no change, whereas that of complexin II
decreased at 6 hrs and remained depressed up to 24 hrs following FPI. It is thus likely
that there exists a dysregulation between the messenger RNA level and that of protein
level, and that this dysregulation is associated with oxidative stress-reÏated events,
since antioxidant treatment inhibits the transient increase in both complexins protein
levels following injury (Article 2, Figure 5).
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_________________
and excitotoxic in] ury
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N-acetylcysteine of neurotraismission
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0f excitotoxic in] ury
and Neuronal Ioss
Figure 3.1. Simptified c&tgram demenstrating the progression of
neuronal toss cuzd excitotoxic iijuiy and their association with
oxidative stress-retated atteration of comptexins tevet. Note that the
action ofN-acetylcysteine on reducing oxidative stress is upstrearn
of hie alteration of compiexins and exacerbation of excitotoxic
damage.
Qualitative assessment of oxidative damage has shown increased 3-
Nitrotyrosine (NT)-positive neurons in the injured cortex following FPI that displayed
similar localization with complexin I and II (Article 2, figure 3). It seems likely,
therefore, that oxidative damage in neurons foflowing trauma may 5e responsible for
the altered level of complexins detected in the injured cortex. Treatment with N
acetylcysteine significantly reduced the number of NT-positive neurons, and
completely abolished the transient rise in complexins in the injured cortex area,
suggesting the alteration of complexins to lie downstream of the oxidative stress
related event (Figure 3.1).
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3.2.2. Localization of complexins and its role in the brain
Localization study in cerebral cortex and hippocampus showcd compiexin I to
be found mostiy in axosornatic synapses whereas compiexin II in axospinai and
axodendritic, suggestive of inhibitory and excitatory synapses, respectiveiy (Yamada
et ai., 1999). However, this is not the case for ail brain regions, since in mouse
striatum compiexin II messenger RNA is expressed by inhibitory output neurons
(Freeman and Morton, 2004). This, with the iack of knowledge of the exact function
of these proteins, makes it difficuit to interpret the present resuits. Moreover, a new
report of other forms of compiexins III and IV in the brain and at the Ribbon synapse
ofretina represents an additionai levei ofcompiexity to the story (Reim et ai., 2005).
Both compiexin I -I- mice (Glyim et ai., 2005) and compiexin II -I- (Giynn et
al., 2003) mice survive whereas the double mutant of complexin I and II -I- die at birth
(Reim et ai., 2001). Compiexin I -I- mice show severe ataxia, tremor and dystonia
whereas complexin II -I- mice show abnormalities in expioration and sociai behavior,
subtie progressive deficits in motor coordination, iearning and reversai iearning
(Giynn et ai., 2003; 2005). In experimentai Wernicke’s encephaiopathy, there is a
downreguiation of both compiexin I and II proteins in the thaiamic area, and this
downreguiation is rescued by N-acetyicysteine treatment (Hazeil and Wang, 2005),
suggesting the depietion is mainiy due to oxidative stress-related events. Since
compiexin I is highiy expressed in thalamus, and considering the ftinctional
significance of the thalamus in reiaying information from the cerebrai cortex to
cerebeiium and basai gangiia thus contributing to higher-order controi, loss of
complexin I protein in the thalamus of experimental Wernicke’ s encephaiopathy may
aiso contribute to the deveiopment of ataxia and ioss of righting reflexes. In the
injured cerebrai cortex of FPI rats, the transient rise in complexin ievels may reflect
increased sensitivity to Ca2tdependent reiease of neurotransmitters, while the loss in
the complexin I ievel in the injured cerebrai cortex and hippocampus at iater time
points foilowing trauma may predispose towards an increased iikelihood of post
traumatic seizure activity.
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3.3. Involvement of oxidative stress in glutamate transporter regulation
following FPI
3.3.1. Lack of effect ofN-acetylcysteine on the loss of GLT-lv early following TBI
Treatrnent of rats with N-acetylcysteine post-injury reduced the early transient
increase in protein content of complexins I and II in the injured cerebral cortex, as
well as decreased the injured volume and neuronal loss of the region. However, the
sarne treatment failed to block the decreased GLT-lv level in the injured cerebraÏ
cortex detected following FPI (figure 3.2), despite the fact that NAC treatrnent
reduced the amount of detectable 3-Nitrotyrosine immunoreactivity. This suggests that
the loss of GLT- 1v immunoreactivity is an independent event from that of oxidative
stress and runs parallel to the oxidative stress-induced alteration of neurotransmitter
release/neuronal injury, reflecting a more complex pathophysiology.
The early detection of increase in irnmunoreactivity of 3-nitrotyrosine (as early
as 6 hr) suggests that there may be nitrosative damage following injury, and potential
production of 0N00 that might contribute to the inactivation of glutamate transport
function (Trotti et al., 1996), in addition to the proposed alterations in complexin
levels (Article 2). Thus, the reduction in the injury volume by NAC treatrnent
following FPI may be due to the reduction of 0N00 production and reduction of
transporter inactivation that occurs early in the injury process. This represents a valid
and interesting avenue for research following that presented in this work and merits
further consideration.
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TBI+NAC
sham 6h 24h
106 kDa
7SkDa
5OkDa
figure 3.2. Representative bandsfor GLT-Iv
immunoblots. Sham i,jwy (sham,), 6h 7 with NAC
(6h ÏBINAC), and 24 h TBJ with NAC (24h TBI-1-N4 C)
in the cerebrai cortex ofthe ratfottowing fPI of
moderate severlly.
3.3.2. Oxidative cross-]inking of glutamate transporters at later stages of TB1
suggests mvolvement of oxidative damage-related dysfunction of
glutamate transporter
Though there is no significant change in the protein levels of GLT-1Œ and
GLAST itt the injured cerebral cortex of FPI rats, there is, however, an increased
injury-dependent cross-linking of glutamate transporters. When protein samples were
prepared according to our protocol, a certain percentage of glutamate transporter
oligomer bands appear that is irreversibly cross-linked by reducing agent DTT. When
mn under non-reducing gel and blotted against GLT-ÏŒ— and GLA$T-specific
antibodies, protein samples of injured cerebral cortex at days 3 and 7 following injuly
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showed an additional increase in the band intensity of oligomers at the expense of
monomer band (figure 33). Tnterestingly, this was fiully reversible under reducing
conditions (figure 3.4), suggesting a likelihood of severe tissue oxidation-induced
$D$-independent sulfhydiyl cross-linking of glutamate transporters (Haugeto et al.,
1996). This was an injury specific event that oiily occurred in the trauma-affected
ipsilateral cerebral cortex ofday 3 and 7 TBI rats prepared under saine conditions (and
not before), when cross-compared with the contralateral brain of the saine animal on
the gel.
GLT-1Œ
__
__
__
_
25OkDa —
l6OkDa —
lO6kDa —
75kDa —
5OkDa
35kDa —
Figure 3.3. Enhanced muiimer formation of GLT-Ia and GLAST
glutamate transporter proteins at days 3 and 7fotÏowing trauma in the
ftjured cerebraÏ cortex. Samptes were loaded in a 3-8% gradient gel anti
min under reducing conditions. Arrows indicate the presence qfmuttimer
Jorms ofthe transporters.
At present, it is unclear as to whether the oligomerization promoted at these
turne points represents solely cross-linking of glutamate transporters to themselves, or
the involvement of other protein(s) as weil and thus a non-specific protein aggregate
GLAST
b
b
b
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formation. When beta-actin was immunoprecipitated ftom the injured cerebral cortex
with monoclonal beta-actin primary antibody at day 3 following FPI, the resulting
immunoprecipitation product was flot immunoreactive with glutamate transporters
GLT-la or GLAST primary antibody, suggesting the potential involvement of beta
actin molecules in the transporter oligomerization is unlikely. further studies are
required to determine whethef other proteins are involved.
250 kDa —
160 kDa —GLT-la lO6kDa
75 kDa —
SOkDa—
Reducing Non- reducinq
condition condition
sham 6h 24h 3d 7d sham 6h 24h 3d 7d
—
——
———MI — — -—
250 kDa
l6OkDa
106 kDa—
75 kDa —
50 kDa —
Reducing Non-reducing
condition condition
sham 6h 24h 3d 7d sham 6h 24h 3d 7d
.7 4
_.,w_u e .. e
Figure 3.4. Reversibte oxidative cross-tinkmg of GLT-Ja and GLAST
occur al days 3 and 7 «fier fPJ but nol al cartier time points. Sainptes
were run under reducing conditions (lefi) or non—reducing conditions
(right) and imrnwîobloltedwiih GLT-laor GLASTantibodies.
The rat glutamate transporters EAACI, GLT-1, and GLAST carry 6, 9 and 3
cysteine residues in their sequences respectively. An in vitro study suggests that the
oxidation and cysteine sulfhydryl cross-linking of glutamate transporters GLTÏ,
GLA$T and EAACI signiflcantly reduces glutamate uptake and uptake associated
current, and this was reversible by application of reducing agent DTT (Trotti et al.,
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1 997a, 1 997b, and reviewed in 1998). Given the extent of oxidative cross-linking seen
in the injured cerebral cortex, it is likely that the glutamate transport activity of GLT
1 es’. and GLA$T is significantly reduced despite the lack of detection of decreased
protein levels at these time points. Based on the knowledge that the extensive
oxidative cross-linking may resuit in the proteolytic degradation process, it may be
possible that a slow degradation of glutamate transporters develops in this brain region
at rnuch later time points. This interesting event, in conjunction with the early
detection of protein nitrotyrosine suggests an involvernent of oxidative stress-related
inactivation in the function of glutamate transporters with no direct connection to
losses in glutamate transporter protein levels following FPI.
3.4. Discussion on key points of Article 3; EAAT4 protein increases in the
hippocampus followïng FPI
Although the loss of glutamate transporter GLT- let and GLAST reported in
CCII (Rao et al., 1998) was not seen at early time points following FPI, it is possible
that the loss in glutamate transporter levels could occur at later times, this being part
of the rationale for extending the tirne points investigated following FPI. When
glutamate transporter levels were examined at later time points (3 days and 7 days)
following FPI, there was little or no difference in the imniunoblot intensity of GLT- let,
GLAST and EAAC1 in the injured cerebral cortex, whereas GLT-lv levels were low
and sustained up to 168 hrs in the injured cerebral cortex (unpublished findings). Thus,
it became rather clear that in this model of experimental trauma, there was no
downregulation of GLT-let and GLAST, but only GLT-lv, unlike the case of CCII
(Rao et al., 199$). However, when another sodium-dependent glutamate transporter
EAAT4 was examined, an increased level in the injured brain at these later time points
was detected.
EAAT4 protein levels studied by semi-quantitative immunoblotting revealed
that, in the injured hippocampus, there was a modest increase of 20 and 25
% following 72 hrs and 16$ hrs trauma, respectively (Article 3). A sirnilar increase
was not seen in other regions such as injured cerebral cortex and thalamus by this
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method, probably due to very low arnounts of EAAT4 in the forebrain (Deimes et al.,
199$). Surprisingly, when studied via immunohistochemistry, this increase was
primarily astrocytic in nature. When normal brain sections were re-examined by
EAAT4 immunohistochemistry, astrocytic staining was detected, albeit low,
throughout white matter tracts of the forebrain and also in the granule celI layer of
cerebellum (Article 3, Figure 1) as well as in the brainstem area. Very little or no
astrocytic staining was detected in the grey matter of forebrain region.
The injured cerebral cortex showed a heterogeneous induction of EAAT4,
where sorne areas showed increase and others no increase in the affected hemisphere.
In the hippocampus 3 and 7 days afier trauma, however, the EAAT4 positive
ilnrnunoreactivity was more or less homogeneous. In the injured thalamus area,
EAAT4 labeling was even less than that of cerebral cortex. This regionaÏ disparity in
increased EAAT4 levels, along with the low basal level of this protein may account
for the lack of detection of significant increase in these two areas, when examined by
immunoblouing. At the earlier time points such as 6 or 24 hr following trauma,
EAAT4 labeling was no different than that of sham brain, suggesting this increase is a
late event.
3.4.1. Specificity of immunolabeling
Several important matters should be considered regarding this study. First, the
literature indicates the EAAT4 transporter is expressed exclusively in fleurons, rnostly
in cell body and dendrites of Purkinje cells in the molecular layer of cerebellum in
normal rat brain (Dehnes et al., 199$). Using EAAT4 antibody, a small fraction was
immunoprecipitable from the forebrain region, whereas immunohistochernistry failed
to demonstrate any detectable labeling in this area (Delmes et al., 199$). However,
there are some references supporting an astrocytic EAAT4 localization in the retina,
spinal cord and forebrain of rat and mice (Ward et al., 2004; Ru et al., 2003), as well
as in hippocampus (Furuta et al., 1997). It rernains questionable as to whether this
EAAT4 labeling represents labeling of the EAAT4 glutamate transporter, since none
of the reports included a knockout study to support their finding, including that of
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Delmes et al (199$).
The second issue is the presence of nuclear staining in the
immunohistochernical sections displayed in this study. EAAT4 is a glycosylated
membrane protein and hence the presence of nuclear staining can pose a serious doubt
about the reliability of our findings. In addition, observation of nuclear staining is flot
uncommon and likely to represent artifactual resuit when high phosphate buffer is
used; this nuclear staining was later cornpletely eliminated by increasing the blocking
condition and replacing the PB$ buffer with TBS (Figure 3.5) in the
immunohistochemical condition. This method was preferred as the antibody
performance is at its best in the condition it is affinity-purffied (TBS) (Lehre and
Danbolt, 1995). Despite the significant reduction of nuclear staining, the astrocytic
staining persisted (or became even more pronounced), supporting the notion of low
basal astrocytic EAAT4 expression throughout the white matter of forebrain region
(Ru et al., 2003).
$ince the astrocytic labeling of EAAT4 resembled that of GFAP, it was
possible that the staining pattern represents a non-specific cross-reactivity with GFAP,
based on the similarity of cytoplasmic/cytoskeletal labeling. This is an interesting
possibility, since the antibody used for present study is flot a monoclonal one, and the
extent of purity and hornogeneity of the antibody is not well defined. Although the
answer to the antibody specificity rernains unclear at this tirne, it is an interesting point
as to why some astrocytes are stained positive for EAAT4 and that flot ail GFAP
positive astrocytes are stained positive for EAAT4 in the region. In the cerebral cortex
and hippocampus, EAAT4 labeled astrocytes are scarce or flot present in the grey
matter, but instead are concentrated in the corpus callosum and internai capsule. In
addition, EAAT4-labeled astrocytes resemble fibrous astrocytes, and it is difficuit to
tell whether the labeling is cytoskeletal or membranal at the light microscope ievel
(Figure 3.5). This puts the notion of a cross-reactivity theory in doubt, though it does
not coinpletely rule out a possible cross-reactivity that is of non-GFAP but selectively
astrocytic in nature. The epitope sequence of EAAT4 antibody used in this study is
sarne as that used in Dehnes et al (199$), where the antigenic sequence corresponds to
the C-terminal sequences of rat EAAT4. The antibody that gave rise to mice spinal
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cord and rat retinal astrocytes used by Hu et al (2003) and Ward et al (2004) study
came from a commercially availaMe source (Alpha Diagnostic, San Antonio, Texas,
USA), and the C-terminal targeting antigenic sequence differs ftom that used in this
study. Thus, at least two different antibodies have been used to support the astrocytic
labeling in the rat and mice brain. If the non-specific cross-reactivity appears specific
by more than one observer, it is Ïikely to be speci±ic labeling unÏess proven otherwise.
(A) (B)
-w
-w
-w
I
Figure 3.5. EAA T4 imtnunohistochemistiy in coronal section of rat cerebellum 3 days
following FF1. Bar; 0.2 mm for B, and 50 5tun for C anct D. In J). Arrows point to
astrocytic labeting in ihe grcunde layer of cerebetiwn, wtiereas corow heads point
toward Furkiîje celis. Method modifiedfrom Lehre and Danbolt (1992).
When examined under other laboratoiy settings (Dehnes et al., 199g), there
was no detectabie EAAT4 immunoreactivity at ail in the forebrain region using 0.47
(C) (D)
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jig/ml antibody. This is in direct conflict with the very same study showing
immunoprecipitable amounts of EAAT4 present in the forebrain region, as well as our
western blot study showing trace amounts of the protein in the cerebral cortex and
hippocampus area. It is very difficuit to embrace our labeling as being a non-specific
cross-reactivity because; 1. The relative staining intensity is in alignment with the
immunoblot data when compared between sainples from forebrain regions and that of
cerebellum; 2. At least 3 different investigators (laboratories) utilizing at least 2
different antibodies prepared with different epitope sequences have shown similar
results.
Following trauma, reactive gliosis occurs as early as 24 hrs whereas the
increase in EAAT4 positive astrocytic labeling only appears at later time points (72
and 168 hrs). The EAAT4 immunoblot band showed both monomer and dimer
constituents in the hippocampus that are at the appropriate molecular weight (64 kDa
and 130 kDa, respectively), and do flot show bands ofother molecular weight. Overail,
there are several observations that presently support the likelihood of astrocytic
EAAT4 increase in the forebrain region in response to FPI. This astrocytic labeling
should eventually be verified using EAAT4 knockout mice.
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4. Conclusions
Clearance of glutamate in the brain is performed by a farnily of sodium
dependent glutamate transporters. Because the termination of glutamatergic synaptic
signais is performed mainly by uptake of glutamate by these transporters, it is crucial
to maintain normal levels of these proteins for proper clearance of glutamate. A
compromise of this situation can produce excitotoxicity via a rise in the interstitial
glutamate concentration.
In this thesis, it was initially considered that protein levels of GLAST and
GLT-1 decrease following experimental trauma which contributes to the rise in brain
interstitial glutamate concentration observed in this model. Instead, GLT-lv, a splice
variant of the glutamate transporter GLT- 1 et, decreases progressiveÏy in the injured
cerebral cortex acutely (6 and 24 hrs) following fPI that correlates positively with the
neuronal loss seen in the same area. At the same tirne, other glutamate transporters
showed little or no change. In addition, there was little or no indication of changes in
the levels of other glutamate transporters in the injured cerebral cortex at later time
points (days 3 and 7) following FPI, while GLT-lv is sustained at low levels up to 7
days following trauma. On the other hand, EAAT4 protein levels were increased at
these time points following FPI throughout the injured hemisphere and appeared to be
also astrocytic in its localization. This rise in EAAT4 levels at later time points may
therefore represent a compensatory mechanism to counteract the decrease in GLT- 1v
levels detected in the injured brain.
Also considered was the possibility that alterations in complexin levels may
contribute to the increase in the extracellular glutamate levels known to occur
following brain trauma. Experimentally, it was shown that an early transient increase
in protein content of complexin II occurred following brain injury that appeared to be
due to oxidative stress. This upregulation in complexin II may be partly responsible
for the acute increase in interstitial glutamate concentration seen in this model. The
results also indicate that oxidative stress may exacerbate brain injury in this model, as
N-acetylcysteine reduced injury volume and neuronal loss.
I A
I ‘f)
At days 3 and 7 following trauma, glutamate transporters in the injured
cerebral cortex displayed evidence of oligomerization, migrating at higher molecular
weights Tepresentative of multimers. This finding also supports the notion that
oxidative damage affects the post-traumatic brain, in this case causing transporter
proteins to form sulfhydryl bonds. Such a condition has previously been reported to
reduce glutamate transport activity in vitro (Trotti et ai, 1997a).
Overali, these resuits provide evidence of excitotoxic damage in which
oxidative stress influences both glutamate transporter flrnction and regulation of
complexin levels. Oxidative stress gives rise to a transient increase in complexin I and
U levels in the injured cortex, which may result in more neurotransmitter release.
Glutamate transporter GLT-lv protein levels decrease in a paraflel but independent
fashion, contributing to the excitotoxic event in the injured cerebral cortex. At later
times, however, oxidative stress facilitates suffliydryl cross-linking of glutamate
transporters GLTlŒ and GLA$T that can ffirther exacerbate the excitotoxic injury.
Figure 41. Seheinatic diagram summarizing events foltowing FF1.
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These resuits are summarized in figure 4.1. Thus, it appears that irnpaired glutamate
uptake due to altered levels of glutamate transporters, in conjunction with changes in
neurotransmitter release due to altered complexin levels, together play an important
role in the pathophysiology of IBI.
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